Organon & Co.
OGNHealthcare|Drug Manufacturers - General|US
$13.87
+0.08 (+0.58%)
DCF Value
$30.78
Graham Number
$9.11
Cash / Share
$5.54
Clinical Trials (532)
| Trial | Conditions | Phase | Status | Enrollment | Design | Drug |
|---|---|---|---|---|---|---|
| NCT06175832 PPOS (Progestin Primed Ovarian Stimulation) and Corifollitropin Alfa (CFA) Cross-over Study | Ovarian Stimulation, Quality of Life | P4 | Recruiting | 60 | RCT, Open-label | Elonva®, Puregon®, Orgalutran®, Gonapeptyl®, Cerazette® |
| NCT06561321 Study to Evaluate the Safety and Efficacy of Tapinarof in Adults With Palmoplantar Keratoderma | Palmoplantar Keratoderma | P2 | Active | 6 | Open-label | Tapinarof |
| NCT00380627 Quality of Life With Arcoxia in Women With Dysmenorrhea (0663-094) | Pain | P4 | Completed | 337 | Open-label | MK0663, Arcoxia, etoricoxib / Duration of Treatment: 3 Days |
| NCT00652717 Study To Assess The Efficacy Of A Cholesterol Lowering Drug On Top Of Statins In Patients After Myocardial Infarction (MI)(0653A-150) | Cardiovascular Disorder | P4 | Completed | 280 | RCT, Open-label | Ezetimibe, simvastatin |
| NCT01277822 Efficacy of Losartan + Amlodipine Compared to Amlodipine Alone in the Treatment of Uncontrolled High Blood Pressure (MK-0954F-399) | Hypertension | P4 | Completed | 334 | RCT, Double-blind | Losartan (+) amlodipine, Placebo to match losartan/amlodipine tablets, Amlodipine camsylate, Placebo to match amlodipine |
| NCT00817050 Single Dose Crossover Study of Patient Preference for Unscented Nasonex® Nasal Spray Versus Scented Flonase® Nasal Spray (Study P04207) | Allergic Rhinitis | P4 | Completed | 100 | RCT, Double-blind | Mometasone Furoate Nasal Spray, fluticasone nasal spray |
| NCT01587235 A Study to Evaluate the Efficacy and Safety of Vytorin Versus Standard Treatment of Other Statins in Moderate, Moderately High and High Risk Participants (MK-0653A-406) | Dyslipidemia | P4 | Withdrawn | — | RCT, Open-label | Ezetimibe/simvastatin, Other Statin |
| NCT00442559 Montelukast in Mild Asthmatic Children With Allergic Rhinitis (0476-367) | Asthma, Allergic Rhinitis | P4 | Completed | 191 | RCT, Open-label | montelukast sodium, inhaled corticosteroid |
| NCT00783211 Efficacy and Safety of Desloratadine vs. Fexofenadine 180 mg. vs. Placebo for Treating Seasonal Allergic Rhinitis (SAR)(Study P04053)(COMPLETED) | Seasonal Allergic Rhinitis | P4 | Completed | 722 | RCT, Double-blind | desloratadine, fexofenadine, placebo |
| NCT00779116 Multi-center, Pediatric, Open-label, Preference Study of Desloratadine 2.5 mg Reditab (SCH34117) and Zyrtec 5.0 mg Chewable Tablet Medications (Study P04574)(COMPLETED) | Allergies | P4 | Completed | 217 | RCT, Open-label | Desloratadine, Zyrtec® (cetirizine) |
| NCT00650663 Ezetimibe Plus Simvastatin Versus Simvastatin Alone in African-American Subjects With Primary Hypercholesterolemia (P03377) | Hypercholesterolemia, Atherosclerosis | P4 | Completed | 247 | RCT, Double-blind | Ezetimibe + Simvastatin, Simvastatin |
| NCT00795522 An Open-Label Study of the Effects of Desloratadine (Aerius.) Treatment on the Quality of Life of Patients With Chronic Idiopathic Urticaria (Study P02540) | Urticaria | P4 | Completed | 51 | Open-label | Desloratadine |
| NCT00431431 Comparison of Tibolone and Raloxifene on Bone Mineral Density in Osteopenic Postmenopausal Women (P06090) | Osteopenia | P4 | Completed | 324 | RCT, Double-blind | tibolone, raloxifen |
| NCT00140959 Losartan and HCTZ and Amlodipine vs Atenolol and Amlodipine (0954A-309)(COMPLETED) | Hypertension | P4 | Completed | 120 | RCT, Open-label | MK0954, losartan potassium/Duration of Treatment: 18 weeks, Comparator: losartan, HCTZ, amlodipine, atenolol/Duration of Treatment: 18 weeks |
| NCT00653835 Ezetimibe Plus Simvastatin Versus Simvastatin in Untreated Subjects With High Cholesterol (P03435) | Hypercholesterolaemia, Atherosclerosis | P4 | Completed | 153 | RCT, Double-blind | Ezetimibe + Simvastatin, Simvastatin |
| NCT00311844 A Study of the Effects of Desloratadine on Conjunctival Allergen Challenge-induced Ocular Signs and Symptoms (Study P04209) | Conjunctivitis, Allergic | P4 | Completed | 41 | RCT, Double-blind | desloratadine |
| NCT01431508 A Study of Safety and Efficacy in MK-0954A Combination in Participants With Hypertension (MK-0954A-373 AM3) | Hypertension | P4 | Completed | 15 | Open-label | Losartan 50 mg / HCTZ 12.5 mg |
| NCT00140985 Antiproteinuric Efficacy of Losartan Potassium in Patients With Non-Diabetic Proteinuric Renal Diseases (0954-213) | Renal Disorder | P4 | Completed | 97 | RCT, Double-blind | MK0954, losartan potassium/Duration of Treatment: 20 weeks, Comparator: amlodipine / Duration of Treatment: 20 weeks |
| NCT05510063 Pharmacokinetics, Efficacy, Safety, and Immunogenicity of SB5 Versus Humira in Subjects With Moderate to Severe Chronic Plaque Psoriasis | Plaque Psoriasis | P4 | Completed | 371 | RCT, Double-blind | Humira (Adalimumab), SB5 (Adalimumab Biosimilar) |
| NCT00442351 Efficacy and Tolerability of Maintenance Treatment With Asmanex Twisthaler Versus Placebo in Mild/Moderate Persistent Asthmatics (Study P04654)(TERMINATED) | Asthma | P4 | Terminated | 26 | RCT, Double-blind | Asmanex twisthaler |
| NCT00867191 Comparison of the Effects of Desloratadine and Placebo in the Relief of Nasal Symptom Scores in Subjects With Seasonal Allergic Rhinitis to Cypress Pollen (Study P02836) | Seasonal Allergic Rhinitis | P4 | Completed | 233 | RCT, Double-blind | Placebo, Desloratadine |
| NCT00202904 Effectiveness and Safety of Ezetimibe Added to Atorvastatin in Patients With High Cholesterol and Coronary Heart Disease (Study P03740) | Hypercholesterolemia, Coronary Heart Disease | P4 | Completed | 81 | RCT, Double-blind | ezetimibe, placebo |
| NCT00545324 First Step With Singulair® Therapy (0476-323) | Asthma | P4 | Completed | 399 | RCT, Open-label | MK0476 (singulair), montelukast sodium / Duration of Treatment: 6 Weeks, Comparator: Fluticasone / Duration of Treatment: 6 Weeks |
| NCT00157924 Ezetimibe (+) Simvastatin vs. Atorvastatin Comparative Study in DM or Metabolic Syndrome Patients (0653A-093) | Hypercholesterolemia | P4 | Completed | 190 | RCT, Open-label | simvastatin (+) ezetimibe, atorvastatin |
| NCT00794846 Preference for Clarinex Tablets vs. Zyrtec Tablets in Patients With Allergies (P03180) | Seasonal Allergic Rhinitis, Perennial Allergic Rhinitis | P4 | Completed | 124 | RCT, Open-label | Desloratadine 5 mg (Clarinex), Cetirizine (Zyrtec) |
| NCT00553891 Placebo-controlled Trial With Nasonex for Nasal Obstruction Secondary to Adenoids Hypertrophy in Children (P04367)(TERMINATED) | Nasal Obstruction, Adenoids Hypertrophy | P4 | Withdrawn | — | RCT, Double-blind | mometasone furoate nasal spray, placebo nasal spray |
| NCT00142558 A Study Evaluating the Effect of Etoricoxib and Indomethacin in the Treatment of Acute Gout (0663-081)(COMPLETED) | Acute Gout | P4 | Completed | 180 | RCT, Double-blind | MK0663; etoricoxib / Duration of Treatment: 5 Days, Comparator: indomethacin 75 mg sustained release capsule / Duration of Treatment: 5 Days |
| NCT00140972 A Study to Assess Etoricoxib Versus Diclofenac in Chinese Patients With Osteoarthritis of the Knee or Hip (0663-080)(COMPLETED) | Osteoarthritis | P4 | Completed | 160 | RCT, Double-blind | MK0663; etoricoxib / Duration of Treatment:4 Weeks, Comparator: diclofenac sodium tablet 75 mg / Duration of Treatment:4 Weeks |
| NCT00536380 Study for the Treatment of Chronic Idiopathic Urticaria With High Doses of AERIUS (Desloratadine) (Study P04849) | Chronic Idiopathic Urticaria | P4 | Completed | 314 | RCT, Double-blind | 5-mg Desloratadine, 10-mg Desloratadine, 20-mg Desloratadine |
| NCT00431093 Trial to Compare the Effects of Tibolone (Livial®) and Continuous Combined Low-Dose Estradiol/Noresterone (Activelle®) | Menopause | P4 | Completed | 570 | RCT, Double-blind | tibolone, low-dose estradiol/noresterone |
| NCT01350934 A Study to Evaluate Alendronate Sodium /Vitamin D3 Combination Tablets(FOSAMAX PLUS) Versus Calcitriol in the Treatment of Osteoporosis in Postmenopausal Women in China (MK-0217A-264) | Osteoporosis, Postmenopausal | P4 | Completed | 219 | RCT, Open-label | alendronate 70-mg/vitamin D3 5600 IU combination tablet (Fosamax Plus), Calcitriol |
| NCT00834119 Assessment of Intranasal Steroids in Allergic Rhinitis When Used Alone or in Combination With an Oral Antihistamine (Study P03270) | Rhinitis, Allergic | P4 | Completed | 72 | Open-label | Mometasone furoate, Mometasone furoate |
| NCT00780403 Multi-Center, Pediatric, Open-Label, Preference Study of Desloratadine 2.5 mg Reditab (SCH34117) and Zyrtec ® 5.0 mg Chewable Tablet Medications (Study P04573) (Completed) | Allergies | P4 | Completed | 220 | RCT, Open-label | Desloratadine, Zyrtec® (cetirizine) |
| NCT00140946 A Study to Assess the Effect of Montelukast Sodium With Concomitant Administration of Inhaled Budesonide in Asthmatic Patients (0476-075) | Asthma | P4 | Completed | 546 | RCT, Double-blind | MK0476; montelukast sodium/Duration of Treatment: 16 weeks, Comparator: placebo / Duration of Treatment: 16 weeks |
| NCT00651963 Open Label Study Evaluating The Use Of Combination Therapy Of Ezetimibe And Statins In Patients With Dyslipidemia In Colombia (0653-141)(COMPLETED) | Lipid Metabolism Disorder | P4 | Completed | 80 | Open-label | ezetimibe |
| NCT00871351 Evaluation of Ezetimibe and Atorvastatin Coadministration Versus Atorvastatin or Rosuvastatin Monotherapy in Japanese Patients With Hypercholesterolemia (Study P06027)(COMPLETED) | Primary Hypercholesterolemia | P4 | Completed | 125 | RCT, Open-label | Ezetimibe, Atorvastatin, Atorvastatin, Rosuvastatin |
| NCT00794495 Preference for Clarinex Tablets vs. Zyrtec Tablets in Patients With Allergies (P03181) | Seasonal Allergic Rhinitis, Perennial Allergic Rhinitis | P4 | Completed | 122 | RCT, Open-label | Desloratadine 5 mg (Clarinex), Cetirizine (Zyrtec) |
| NCT00652327 Comparison of Ezetimibe Added to Ongoing Statin Therapy Versus Doubling the Dose of Statin in the Treatment of Hypercholesterolemia (P04355) | Hypercholesterolemia | P4 | Completed | 83 | RCT, Open-label | Ezetimibe + Statin (simvastatin, atorvastatin, or pravastatin), Double Statin (simvastatin, atorvastatin, or pravastatin) |
| NCT00090181 Study of MK0663 in Patients With Chronic Low Back Pain (0663-806)(COMPLETED) | Chronic Low Back Pain | P4 | Completed | 401 | RCT, Double-blind | MK0663, etoricoxib / Duration of Treatment: 4 weeks, Comparator: diclofenac / Duration of Treatment: 4 weeks |
| NCT00652847 Randomized Parallel Group Trial Of The Efficacy And Safety Of Ezetimibe With A Statin Versus Statin Dose Doubling In Patients With Persistent Primary Hypercholesterolemia (0653-152)(COMPLETED) | Hypercholesterolemia | P4 | Completed | 1,140 | RCT, Open-label | ezetimibe, statins |
| NCT00359138 The Duration of the Suppressive Effects of Desloratadine on Allergen Prick Tests After Discontinuation (P04441) | Hypersensitivity | P4 | Completed | 36 | RCT, Double-blind | desloratadine, levocetirizine, Desloratadine placebo tablet, Levocetirizine placebo capsule |
| NCT00783133 Preference for Clarinex Tablets vs. Allegra Tablets in Patients With Seasonal Allergies (Study P03177) | Seasonal Allergic Rhinitis | P4 | Completed | 131 | RCT, Open-label | Desloratadine 5 mg, fexofenadine |
| NCT00521599 A Study of the Equivalent Effectiveness of 400 mcg Mometasone Furoate Using Two Different Dry Powder Inhalers in Moderate Asthmatics (Study P04828) | Asthma | P4 | Completed | 672 | RCT, Double-blind | Mometasone furoate dry powder inhaler, Placebo |
| NCT00496834 LAAS (Losartan Anti-Atherosclerosis Study)(0954-330)(COMPLETED) | Hypertension | P4 | Completed | 201 | RCT, Open-label | losartan potassium, Comparator: carvedilol, Comparator: losartan (+) hydrochlorothiazide (HCTZ), Comparator: carvedilol (+) hydrochlorothiazide |
| NCT05761444 Effectiveness and Safety Study of Early add-on of Ezetimibe With Atorvastatin in Very High-risk Patients | Atherosclerotic Cardiovascular Disease | P4 | Completed | 137 | RCT, Open-label | Atozet 10/40 mg or 10/80 mg, Lipitor 40 mg or 80 mg |
| NCT01611883 A Study of the Effect of Ezetimibe on Glucose Metabolism in Type 2 Diabetics With Hypercholesterolemia (P06541) | Hypercholesterolemia | P4 | Completed | 152 | RCT, Double-blind | Ezetimibe, Placebo |
| NCT00794599 Preference for Clarinex Tablets vs. Zyrtec Tablets in Patients With Allergies (P03182) | Seasonal Allergic Rhinitis, Perennial Allergic Rhinitis | P4 | Completed | 118 | RCT, Open-label | Desloratadine 5 mg (Clarinex), Cetirizine (Zyrtec) |
| NCT00756418 Montelukast Post-marketing Comparative Study With Theophyline Added to Inhaled Corticosteroid (0476-396) | Asthma | P4 | Completed | 84 | RCT, Open-label | montelukast, Theophylline |
| NCT00739050 Effect of Simvastatin on Endothelial Function in Premenopausal Women With Systemic Lupus Erythematosus (0733-271)(TERMINATED) | Systemic Lupus Erythematosus | P4 | Terminated | 4 | RCT, Double-blind | simvastatin, Comparator: Placebo |
| NCT00687531 Clinical Trial to Assess Efficacy, Safety, Treatment Adherence and Quality of Life Impact of Mometasone Furoate in Asthmatic Patients (Study P04879)(TERMINATED) | Asthma | P4 | Terminated | 385 | Open-label | Mometasone Furoate |
| NCT00359216 The Effects of Mometasone Furoate Nasal Spray in Subjects With Sleep-disordered Breathing (SDB) Associated With Perennial Allergic Rhinitis (Study P04726) | Perennial Allergic Rhinitis, Obstructive Sleep Apnea | P4 | Completed | 30 | RCT, Double-blind | Mometasone furoate nasal spray, Placebo |
| NCT00783237 Onset of Effect of Mometasone Nasal Spray in Induced Allergic Rhinitis (Study P03431) | Allergic Rhinitis | P4 | Completed | 340 | RCT, Double-blind | Mometasone, Placebo |
| NCT00652444 Effect Of Ezetimibe Coadministration With Simvastatin In A Middle Eastern Population: A Prospective, Multicentre, Randomized, Double-Blind, Placebo-Controlled Trial (0653-151) | Hypercholesterolemia | P4 | Completed | 120 | RCT, Double-blind | ezetimibe, simvastatin, Placebo (Unspecified) |
| NCT00442897 Vytorin (10/20 Or 10/40) Compared to Atorvastatin (10 mg or 20 mg) in Patients With Coronary Artery Disease (0653A-126)(COMPLETED) | Hypercholesterolemia | P4 | Completed | 229 | RCT, Open-label | simvastatin (+) ezetimibe, Comparator: atorvastatin |
| NCT00805584 Study of Nasal Symptom Relief and Side Effects in Hayfever Patients Treated With Aerius (Desloratadine)(P03442) | Rhinitis, Allergic, Seasonal | P4 | Completed | 311 | Open-label | desloratadine |
| NCT00651014 Ezetimibe Plus Simvastatin Versus Simvastatin in Patients With Hypercholesterolemia and Coronary Risk Factors (P03405) | Hypercholesterolemia, Atherosclerosis | P4 | Terminated | 82 | RCT, Double-blind | Ezetimibe, Placebo |
| NCT00358527 Mometasone Furoate on Sleep Disturbances in Subjects With Seasonal Allergic Rhinitis (Study P04608) (COMPLETED) | Seasonal Allergic Rhinitis | P4 | Completed | 401 | RCT, Double-blind | Mometasone Furoate Nasal Spray (MFNS) |
| NCT00751166 A Comparative Double-blind, Double-dummy Study of Desloratadine (DL) 5 mg Once Daily, Cetirizine 10 mg Once Daily, and Placebo Once Daily in Patients With Chronic Idiopathic Urticaria (Study P03736) | Urticaria | P4 | Terminated | 149 | RCT, Double-blind | Desloratadine, Cetirizine, placebo |
| NCT00778999 Predictive Factors for Ovarian Stimulation Using a Fixed Daily Dose of 200 IU Recombinant FSH (Study 142003)(P05696) | Infertility | P4 | Completed | 442 | RCT, Open-label | Marvelon |
| NCT00380523 Analgesic Treatment Mediated by Arcoxia (0663-093) | Pain | P4 | Completed | 237 | Open-label | MK0663, Arcoxia, etoricoxib / Duration of Treatment: 3 Days |
| NCT01490190 Study of the Use of a Contraceptive Vaginal Ring (NuvaRing) in Normal Daily Practice in Indian Women (P07733) | Contraception | P4 | Completed | 252 | Open-label | Ethinylestradiol + Etonogestrel Vaginal Ring (NuvaRing) |
| NCT05789576 A Study to Investigate Efficacy and Safety of VTAMA® (Tapinarof) Cream, 1% in Plaque Psoriasis in the Head and Neck Region | Psoriasis | P4 | Completed | 31 | Open-label | VTAMA (tapinarof) cream, 1% |
| NCT00651378 Switching to Rosuvastatin Versus Adding Ezetimibe to Atorvastatin Versus Doubling the Dose of Atorvastatin in Patients With Hypercholesterolemia and Risk Factors (P03708) | Hypercholesterolemia, Atherosclerosis | P4 | Terminated | 87 | RCT, Open-label | Rosuvastatin, Ezetimibe + Atorvastatin, Double Atorvastatin |
| NCT01098071 Nasonex (Mometasone Furoate Nasal Spray) in Adenoids Hypertrophy in Children (P04367) | Adenoids | P4 | Completed | 34 | Open-label | mometasone furoate nasal spray |
| NCT00545844 Singulair(R) In Asthma And Allergic Rhinitis (0476-383) | Asthma | P4 | Completed | 313 | Open-label | montelukast sodium |
| NCT01044056 A Trial in Healthy Female Subjects to Compare the Pharmacokinetics of Ethinyl Estradiol of NuvaRing®, a Contraceptive Patch (EVRA(TM)) and an Oral Contraceptive (Microgynon® 30) (Study 34237 (P06650)) (COMPLETED) | Contraception | P4 | Completed | 24 | RCT, Open-label | Levonorgestrel (LNG)/Ethinylestradiol (EE) oral contraceptive tablets, norelgestrominum and ethinylestradiol patch oral contraceptive patch, Nuvaring ™ (etonorgestrel/ethinylestradiol) |
| NCT00446056 Montelukast Post-Marketing Comparative Study With Ketotifen (0476-379) | Asthma | P4 | Completed | 188 | RCT, Double-blind | MK0476, montelukast sodium / Duration of Treatment: 4 Weeks, Comparator: ketotifen / Duration of Treatment: 4 Weeks |
| NCT00729651 Efficacy and Safety Study of Fosamax Plus D in Postmenopausal Women With Osteoporosis (0217A-263) | Osteoporosis Postmenopausal | P4 | Completed | 343 | RCT, Open-label | alendronate sodium (+) cholecalciferol, Comparator: Alendronate sodium (Fosamax) |
| NCT00070707 Nasonex Compared With Placebo in Participants With Seasonal Allergic Rhinitis (SAR) and Concomitant Asthma (P03280) | Rhinitis, Allergic, Seasonal, Asthma | P4 | Completed | 188 | RCT, Double-blind | Mometasone, Placebo, Albuterol/Salbutamol |
| NCT00166504 Ezetimibe Plus (+) Simvastatin Versus Atorvastatin Comparative Study (0653A-092)(COMPLETED) | Hypercholesterolemia | P4 | Completed | 203 | RCT, Open-label | ezetimibe (+) simvastatin, atorvastatin |
| NCT00394355 Effects of Mometasone Furoate Dry Powder Inhaler, Fluticasone Propionate, and Montelukast on Bone Mineral Density in Asthmatics (Study P03418) | Asthma | P4 | Completed | 566 | RCT, Double-blind | mometasone furoate dry powder inhaler, mometasone furoate dry powder inhaler, fluticasone propionate hydrofluoroalkane (HFA), montelukast |
| NCT00835094 A Randomized Trial Assessing Once Daily Administration of Mometasone Furoate DPI in Asthmatics (Study P02177) | Asthma | P4 | Completed | 216 | RCT, Open-label | — |
| NCT01471340 A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241) | Asthma | P4 | Completed | 11,744 | RCT, Double-blind | Mometasone Furoate/Formoterol MDI 100/5 mcg, Mometasone Furoate/Formoterol MDI 200/5 mcg, Mometasone Furoate MDI 100 mcg, Mometasone Furoate MDI 200 mcg, Albuterol 90 mcg /salbutamol 100 mcg HFA MDI, Prednisone/prednisolone |
| NCT00398294 To Evaluate the Lipid-Lowering Efficacy and Safety of Simvastatin 40 Mg Tablet In Patients With Hypercholesterolemia (0733-264) | Hypercholesterolemia | P4 | Completed | 30 | Open-label | MK0733, simvastatin / Duration of Treatment: 12 Weeks |
| NCT00794248 Preference for Clarinex Tablets vs. Allegra Tablets in Patients With Seasonal Allergies (Study P03179) | Seasonal Allergic Rhinitis | P4 | Completed | 122 | RCT, Open-label | desloratadine 5 mg, fexofenadine |
| NCT00380705 Quality of Life in Asthma and Rhinitis Allergic With Singulair (0476-365) | Asthma, Rhinitis Allergic | P4 | Completed | 91 | Open-label | MK0476, Singulair, montelukast sodium / Duration of Treatment: 8 Weeks |
| NCT00140881 A Study to Determine the Effect of Montelukast Sodium as an Episode Modifier in the Treatment of Infrequent Episodic Asthma in Children (0476-165) | Asthma | P4 | Completed | 220 | RCT, Double-blind | MK0476; montelukast sodium, Comparator: placebo |
| NCT00751218 A Comparative Double-Blind, Double- Dummy Study of Desloratadine (DL) 5 MG Once Daily, Cetirizine 10 MG Once Daily, and Placebo Once Daily in Patients With Chronic Idiopathic Urticaria (Study P03735) | Urticaria | P4 | Completed | 174 | RCT, Double-blind | desloratadine, placebo, cetirizine |
| NCT00783354 A Comparison of Aerius Continuous Treatment Versus Aerius PRN for Chronic Idiopathic Urticaria (Study P03147) | Urticaria, Chronic Idiopathic Urticaria | P4 | Completed | 129 | RCT, Double-blind | desloratadine, desloratadine |
| NCT00491504 This Study Contains an Active Drug Treatment Group With Mometasone Furoate Nasal Spray and a Placebo (Dummy) Treatment Group for Seasonal Allergic Rhinitis (SAR). (Study P05073)(COMPLETED) | Seasonal Allergic Rhinitis | P4 | Completed | 310 | RCT, Double-blind | Mometasone Furoate Nasal Spray |
| NCT00671528 Safety and Efficacy of Quadriderme® in the Treatment of Impetiginous Eczema (Study P05134AM4) | Dermatitis, Atopic, Eczema, Atopic | P4 | Terminated | 3 | RCT, Double-blind | Cream (betamethasone diproprionate, clotrimazole, and gentamicin sulfate), Cream (betamethasone diproprionate and gentamicin), Cream (betamethasone diproprionate) |
| NCT00757627 Patient-Reported Effectiveness and Safety of Etoricoxib in Osteoarthritis (OA)(0663-113) | Pain | P4 | Completed | 500 | Open-label | etoricoxib |
| NCT00794768 Preference for Clarinex Tablets vs Allegra Tablets in Patients With Seasonal Allergies (P03178) | Seasonal Allergic Rhinitis | P4 | Completed | 118 | RCT, Open-label | desloratadine 5 mg, fexofenadine |
| NCT00534976 The Effect of Montelukast on Difficulty in Breathing After Exercise in Pediatric Patients (MK0476-377)(COMPLETED) | Exercise-induced Bronchoconstriction (EIB) | P4 | Completed | 364 | RCT, Double-blind | Comparator: montelukast sodium, Comparator: Comparator: placebo (unspecified) |
| NCT00653796 Ezetimibe Plus Atorvastatin Versus Atorvastatin in Untreated Subjects With High Cholesterol (P03434) | Hypercholesterolemia, Atherosclerosis | P4 | Completed | 148 | RCT, Double-blind | Ezetimibe + Atorvastatin, Atorvastatin |
| NCT00783146 Efficacy and Safety of Desloratadine vs. Fexofenadine 180 mg. vs. Placebo for Treating Seasonal Allergic Rhinitis (SAR) (Study P04054) | Seasonal Allergic Rhinitis | P4 | Completed | 728 | RCT, Double-blind | desloratadine, fexofenadine, placebo |
| NCT01429168 A Study of Etoricoxib in Participants With Osteoarthritis Not Responding to Analgesic Drugs (MK-0663-142) | Osteoarthritis | P4 | Withdrawn | — | RCT, Double-blind | Etoricoxib, Placebo for etoricoxib |
| NCT00783458 Single Dose Crossover Study of Patient Preference for Unscented Nasonex® Nasal Spray Versus Scented Flonase® Nasal Spray (Study P04208) | Allergic Rhinitis | P4 | Completed | 100 | RCT, Double-blind | Mometasone Furoate Nasal Spray, fluticasone nasal spray |
| NCT00157963 Hydrochlorothiazide (+) Losartan Potassium vs. Amlodipine Comparative Study (0954A-314) | Essential Hypertension | P4 | Completed | 174 | RCT, Open-label | MK0954A; hydrochlorothiazide (+) losartan potassium / Duration of Treatment: 12 weeks |
| NCT00157937 A Study to Compare Effectiveness of Montelukast Sodium With Comparator in Mild to Moderate Persistent Asthmatics (0476-329) | Asthma, Allergic Rhinitis | P4 | Completed | 31 | RCT, Open-label | MK0476; montelukast sodium/Duration of Treatment: 16 weeks, Comparator: theophylline ER/Duration of Treatment: 16 weeks |
| NCT00763529 Elocon vs Fluticasone in Localized Psoriasis (P03197) | Psoriasis | P4 | Completed | 245 | RCT, Open-label | Mometasone, Fluticasone |
| NCT00651274 Comparison of Co-administration of Ezetimibe Plus Simvastatin Versus Simvastatin Alone in Primary Hypercholesterolemia (P03476) | Atherosclerosis, Hypercholesterolemia | P4 | Completed | 144 | RCT, Double-blind | Ezetimibe, Placebo |
| NCT00395408 Linear Growth Study (0476-097)(COMPLETED) | Asthma | P4 | Completed | 360 | RCT, Double-blind | MK0476, montelukast sodium / Duration of Treatment : 56 Weeks, Comparator : beclomethasone dipropionate / Duration of Treatment : 56 Weeks |
| NCT00423579 The Effects of Ezetimibe/Simvastatin 10/20 mg Versus Simvastatin 40 mg in High Cholesterol and Coronary Heart Disease Study (P04039AM2)(COMPLETED) | Hypercholesterolemia, Coronary Disease | P4 | Completed | 120 | RCT, Double-blind | Ezetimibe/Simvastatin 10/20 mg, simvastatin 40 mg |
| NCT00166530 EASEGO Study: Doubling of Atorvastatin/Simvastatin or INEGY in Patients With Hypercholesterolemia and Coronary Artery Disease(CAD)(0653A-089) | Atherosclerosis | P4 | Completed | 367 | RCT, Open-label | ezetimibe (+) simvastatin, simvastatin, atorvastatin |
| NCT00140907 ALLOGRAFT, A Study to Evaluate the Renal Protective Effects of Losartan (0954-222)(COMPLETED) | High Blood Pressure | P4 | Completed | 367 | RCT, Double-blind | losartan potassium, Comparator: Placebo |
| NCT00779636 Effectiveness and Safety of Desloratadine in Patients With Allergic Airway Disease During the Pollen Season (Study P03284) | Allergic Airway Disease | P4 | Completed | 506 | RCT, Double-blind | Desloratadine, Placebo |
| NCT00092092 Study of Montelukast and Its Effect on Lower Leg Growth in Children With Asthma (MK-0476-254) | Asthma, Bronchial | P4 | Completed | 71 | RCT, Double-blind | Montelukast chewable tablets, Budesonide inhaler, Placebo to montelukast chewable tablets, Placebo to budesonide inhaler |
| NCT00319449 Adding Ezetimibe Tablet to Ongoing Treatment With Atorvastatin in Subjects With High Cholesterol and Multiple Coronary Heart Disease Risk Factors (Study P04060)(COMPLETED) | Hypercholesterolemia, Coronary Arteriosclerosis | P4 | Completed | 22 | RCT, Double-blind | Ezetimibe, Placebo, Atorvastatin 10 mg |
| NCT00294463 Effects of Tibolone Treatment on the Endometrium | Postmenopause, Osteoporosis | P4 | Completed | 35 | Open-label | Tibolone, Estradiol, Estradiol + Medroxy Progesterone Acetate |
| NCT00635570 Acceptability of the NuvaRing Among Students | Birth Control Compliance | P4 | Completed | 273 | RCT, Open-label | Ortho Tri-cyclen Lo |
| NCT00349258 The Use of GnRH Agonist Trigger in the Prevention of OHSS | Ovarian Hyperstimulation Syndrome | P4 | Completed | 66 | RCT, Open-label | Leuprolide acetate |
| NCT04047875 Treatment of Prolonged Uterine Bleeding of Etonogestrel (ENG)-Releasing Implant | Breakthrough Bleeding | P4 | Completed | 114 | RCT, Double-blind | Norethisterone 10mg/day, Placebo |
| NCT00269620 PARIS or PAtch RIng Study: A Trial to Evaluate NuvaRing Versus OrthoEvra | Contraception | P4 | Completed | 500 | RCT, Open-label | ethinyl estradiol/etonogestrel vaginal ring, ethinyl estradiol/norelgestromin transdermal contraceptive |
| NCT00461422 Early Follicular Supplementation of Ganirelix in IVF 2004 | Infertility, IVF Treatment | P4 | Completed | 50 | RCT, Open-label | Ganirelix |
| NCT00092703 Investigational Drug Versus an Approved Drug in Patients With Osteoarthritis (0663-061)(COMPLETED) | Osteoarthritis | P3 | Completed | 6,000 | RCT, Double-blind | MK0663, etoricoxib, Comparator: Diclofenac sodium |
| NCT02668783 Efficacy and Safety of Etonogestrel + 17β-Estradiol Vaginal Ring (MK-8342B) in Women With Primary Dysmenorrhea (With Optional Extension) (MK-8342B-059) | Moderate to Severe Primary Dysmenorrhea | P3 | Terminated | 25 | RCT, Double-blind | Etonogestrel (ENG) 125 μg + 17β-estradiol (E2) 300 μg vaginal ring, Placebo vaginal ring, Ibuprofen |
| NCT03882905 A Study of SCH 58235 (Ezetimibe) When Added to Ongoing Therapy With a Statin in Participants With Primary Hypercholesterolemia, Known Coronary Heart Disease, or Multiple Cardiovascular Risk Factors (P02173) | Primary Hypercholesterolemia | P3 | Completed | 769 | RCT, Double-blind | Ezetimibe, Placebo, Simivastatin, Statin |
| NCT00519857 Trial to Evaluate Tibolone in the Treatment of Osteoporosis (P06468) | Osteoporosis | P3 | Completed | 4,534 | RCT, Double-blind | Tibolone, Placebo |
| NCT00974571 Montelukast in Perennial Allergic Rhinitis - 2001-2002 Study (0476-246) | Perennial Allergic Rhinitis | P3 | Completed | 1,365 | RCT, Double-blind | montelukast sodium, Comparator: cetirizine, Comparator: placebo |
| NCT00732368 A Long-term Study of Mometasone Furoate in Patients With Perennial Allergic Rhinitis (Study P04459) | Perennial Allergic Rhinitis | P3 | Completed | 98 | Open-label | Mometasone furoate |
| NCT00092157 Effectiveness of Two Approved Drugs in Lowering High Cholesterol (0733-224) | Hypercholesterolemia | P3 | Completed | 571 | RCT, Double-blind | MK0733, simvastatin, Comparator: simvastatin |
| NCT00092690 MK0653A (Ezetimibe (+) Simvastatin) Compared to an Approved Drug (Atorvastatin) for the Treatment of High Cholesterol (0653A-051)(COMPLETED) | Hypercholesterolemia | P3 | Completed | 1,902 | RCT, Double-blind | MK0653A, ezetimibe (+) simvastatin, Comparator: atorvastatin |
| NCT02460159 A Clinical Trial to Assess the Long Term Safety and Tolerability of MK-0653C in Japanese Participants With Hypercholesterolemia (MK-0653C-384) | Hypercholesterolemia, Heterozygous Familial Hypercholesterolemia | P3 | Completed | 135 | Open-label | EZ 10 mg/Atorva 20 mg FDC, EZ 10 mg/Atorva 10 mg FDC |
| NCT01673620 A Study to Evaluate the Safety of Combination Montelukast/Loratadine in Mexican Participants With Allergic Rhinitis (MK-0476A-484) | Allergic Rhinitis | P3 | Completed | 69 | RCT, Double-blind | Montelukast 10 mg/loratadine 10 mg, Placebo |
| NCT00745108 Tibolone Endometrium Study (Study 32972)(P06470) | Postmenopausal Women | P3 | Completed | 32 | RCT, Double-blind | tibolone, Tibolone 2.5 mg, CE/MPA |
| NCT00650689 Ezetimibe Plus Atorvastatin Versus Atorvastatin in Untreated Subjects With Primary Hypercholesterolemia and Coronary Heart Disease (P03396) | Hypercholesterolemia, Atherosclerosis | P3 | Completed | 122 | RCT, Double-blind | Ezetimibe + Atorvastatin, Atorvastatin |
| NCT01370590 A Study to Evaluate the Effectiveness of Ezetimibe/Atorvastatin 10 mg/20 mg Combination Tablet Compared to Marketed Ezetimibe 10 mg and Atorvastatin 20 mg Tablets in Participants With High Cholesterol (MK-0653C-185 AM1) | Hypercholesterolemia | P3 | Completed | 406 | RCT, Double-blind | Atorvastatin, Ezetimibe, Ezetimibe/atorvastatin, Placebo to atorvastatin, Placebo to ezetimibe, Placebo to ezetimibe/atorvastatin |
| NCT00092066 A Study to Evaluate the Safety, Tolerability, and Efficacy of an Investigational Drug and Dietary Supplement in Men and Postmenopausal Women With Osteoporosis (0217A-227) | Osteoporosis, Vitamin D Deficiency | P3 | Completed | 717 | RCT, Double-blind | MK0217A, alendronate sodium (+) cholecalciferol / Duration of Treatment: 15 weeks |
| NCT00445107 SINGULAIR (R) as Complementary Therapy to Fixed Association Regimen (0476-363) | Asthma | P3 | Completed | 198 | Open-label | MK0476, montelukast sodium / Duration of Treatment: 8 Weeks |
| NCT00092989 Investigation of Intravenous (IV) Administration of an Approved Drug (MK-0476, Montelukast Sodium) for Acute Asthma (MK-0476-288) | Asthma | P3 | Completed | 650 | RCT, Double-blind | montelukast sodium, placebo |
| NCT00604500 A Patient Handling Study of Mometasone Furoate/Formortoral Fumarate (MF/F) Metered Dose Inhaler (MDI) With an Integrated Dose Counter in Adolescent and Adult Subjects With Asthma or Chronic Obstructive Pulmonary Disease (Study P04703AM1) | Asthma, COPD | P3 | Completed | 272 | Open-label | SCH No. 418131 (Mometasone Furoate/Formoterol Furoate abbreviated MF/F ) |
| NCT00894556 A Study to Evaluate the Efficacy and Tolerability of Rizatriptan for Treatment of Acute Migraine (0462-087) | Acute Migraine | P3 | Completed | 109 | RCT, Double-blind | rizatriptan, Comparator: Placebo, Comparator: Sumatriptan |
| NCT00413764 Efficacy of Tibolone Versus Transdermal E2/NETA on Sexual Function in Naturally Postmenopausal Women (P06089) | Sexual Dysfunction | P3 | Completed | 358 | RCT, Double-blind | tibolone, estradiol-norethisterone |
| NCT00479713 A Study to Assess the Cholesterol Lowering Effect of an Ezetimibe/Simvastatin Combination Tablet Compared to Another Cholesterol Lowering Drug in Patients With High Cholesterol and With High Cardiovascular Risk (0653A-809)(COMPLETED) | Hypercholesterolemia | P3 | Completed | 618 | RCT, Double-blind | ezetimibe (+) simvastatin, Comparator : rosuvastatin calcium, Comparator: Placebo (unspecified), Comparator: Placebo (unspecified) |
| NCT03867318 Efficacy and Safety Study of Ezetimibe (SCH 58235, MK-0653) in Addition to Atorvastatin in Participants With Coronary Heart Disease or Multiple Cardiovascular Risk Factors (P00693/MK-0653-030) | Hypercholesterolemia | P3 | Completed | 621 | RCT, Double-blind | Atorvastatin, Ezetimibe, Placebo for Ezetimibe, Placebo for Atorvastatin |
| NCT00423176 The Study of Nasonex® Compared With Placebo for the Relief of Symptoms Associated With Acute Bacterial Sinusitis When Used With Antibiotics (Study P04824AM3) | Sinusitis | P3 | Terminated | 237 | RCT, Double-blind | MFNS and antibiotic, Matching Placebo nasal spray plus antibiotic |
| NCT00794794 Taste Test Between Desloratadine and Cetirizine Syrup in Children (Study P03826) | Allergic Rhinitis | P3 | Completed | 204 | RCT, Double-blind | Desloratadine (Clarinex), Cetirizine (Zyrtec) |
| NCT00812006 A Study of Rizatriptan for the Treatment of Acute Migraine in Patients on Topiramate for Migraine Prophylaxis | Migraine | P3 | Completed | 108 | RCT, Double-blind | rizatriptan benzoate, Comparator: placebo |
| NCT01244828 Long-term Study of Asenapine in Participants With Residual Subtype, Receiving Multiple or/and High Dose Drugs, or Treatment Refractory Schizophrenia (P06238) | Schizophrenia | P3 | Completed | 157 | Open-label | Asenapine |
| NCT00157911 A Study to Evaluate Ezetimibe in Korean Patients With Primary Hypercholesterolemia (0653-042) | Hypercholerolemia | P3 | Completed | 136 | RCT, Double-blind | MK0653; ezetimibe / Duration of Treatment: 12 weeks, Comparator: simvastatin / Duration of Treatment: 12 weeks |
| NCT05172726 Tapinarof for the Treatment of Plaque Psoriasis in Pediatric Subjects | Plaque Psoriasis | P3 | Completed | 58 | Open-label | tapinarof cream, 1% |
| NCT01566149 Study of Mometasone Furoate/Formoterol Fumarate (MF/F) Metered Dose Inhaler (MDI) in Adolescents & Adults With Persistent Asthma (P08212) | Asthma | P3 | Completed | 49 | Open-label | Mometasone Furoate/Formoterol Fumarate (MF/F) 100/5 mcg MDI, Mometasone Furoate/Formoterol Fumarate (MF/F) 200/5 mcg MDI |
| NCT00794378 Taste Test Between Desloratadine and Cetirizine Syrup in Children (Study P03829)(COMPLETED) | Allergic Rhinitis | P3 | Completed | 202 | RCT, Double-blind | Desloratadine (Clarinex), Cetirizine (Zyrtec) |
| NCT00725491 A Study to Assess the Efficacy and Safety of Ganirelix (Orgalutran®) Treatment in Chinese Women Undergoing Controlled Ovarian Stimulation for in Vitro Fertilization (IVF) or Intra Cytoplasmatic Sperm Injection (ICSI) (Study 38651)(P05703) | Controlled Ovarian Stimulation | P3 | Completed | 259 | RCT, Open-label | ganirelix, triptorelin |
| NCT00599027 An Exploratory Study of Nasonex in Patients With Moderate to Severe Persistent Allergic Rhinitis and Intermittent Asthma | Allergic Rhinitis, Asthma | P3 | Completed | 51 | RCT, Double-blind | Mometasone furoate nasal spray (MFNS), Placebo nasal spray |
| NCT02616146 Efficacy and Safety of Etonogestrel + 17β-Estradiol Vaginal Ring and Levonorgestrel-Ethinyl Estradiol Combined Oral Contraceptive in Adult Women at Risk for Pregnancy (MK-8342B-062) | Contraception | P3 | Terminated | 2,016 | RCT, Open-label | ENG-E2 125 μg/300 μg vaginal ring, LNG-EE 150 μg/30 μg COC |
| NCT00764478 Fixed-dose Safety and Efficacy Study of Asenapine for the Treatment of Acute Manic or Mixed Episode in Bipolar 1 Disorder (P05691) | Bipolar 1 Disorder | P3 | Completed | 367 | RCT, Double-blind | Asenapine, Asenapine, Placebo |
| NCT00516737 Study to Test Rizatriptan in the Early Treatment of Acute Migraine (0462-081) | Migraine | P3 | Completed | 207 | RCT, Double-blind | Comparator: rizatriptan benzoate, Comparator: Placebo |
| NCT07265479 A Study to Investigate Safety and Efficacy of Tapinarof Cream, 1% in Participants Ages 3 Months to < 24 Months With Atopic Dermatitis | Atopic Dermatitis | P3 | SUSPENDED | 187 | RCT, Double-blind | Tapinarof cream, 1%, Vehicle Cream |
| NCT00111709 Study to Test a Marketed Drug in the Treatment of Menstrual Migraine (0462-071) | Migraine | P3 | Completed | 393 | RCT, Double-blind | MK0462, rizatriptan benzoate / Duration of Treatment -1 day, Comparator: placebo / Duration of Treatment - 1 day |
| NCT00696800 A Study to Investigate the Efficacy and Safety of a Single Injection of Corifollitropin Alfa (Organon 36286) for Ovarian Stimulation Using Daily Recombinant Follicle Stimulating Hormone (FSH) as Reference (P05787) | In Vitro Fertilization | P3 | Completed | 1,509 | RCT, Double-blind | Corifollitropin alfa, RecFSH / Follitropin beta (Days 1 to 7), Placebo Corifollitropin alfa, Placebo RecFSH / follitropin beta, RecFSH / Follitropin beta (Days 8 to hCG), Ganirelix, hCG, Progesterone |
| NCT00319995 Effects of Loratadine/Montelukast vs Pseudoephedrine and Placebo in Patients With Seasonal Allergic Rhinitis (Study P04095) (COMPLETED) | Rhinitis, Allergic, Seasonal | P3 | Completed | 1,095 | RCT, Double-blind | loratadine; montelukast |
| NCT00480805 HYZAAR vs. Ramipril for Diabetes (0954A-245)(COMPLETED) | Type 2 Diabetes Mellitus, Hypertension | P3 | Completed | 312 | RCT, Double-blind | MK0954A, losartan potassium (+) hydrochlorothiazide (HYZAAR) / Duration of Treatment : 8 Weeks, Comparator : ramipril /Duration of Treatment : 8 Weeks |
| NCT00960141 A Study Investigating the Effect of Montelukast in Patients With Seasonal Allergic Rhinitis (MK-0476-192)(COMPLETED) | Seasonal Allergic Rhinitis | P3 | Completed | 829 | RCT, Double-blind | montelukast sodium, Comparator: loratadine, Comparator: placebo |
| NCT01190254 Fixed Dose Efficacy and Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05896) | Schizophrenia, Paranoid, Schizophrenia, Disorganized | P3 | Completed | 306 | RCT, Double-blind | asenapine 2.5 mg, asenapine 5.0 mg, placebo |
| NCT00418834 Ezetimibe and Atorvastatin vs. Atorvastatin in Patients Age 65 and Older at High Risk for Coronary Heart Disease (CHD)(0653-112) | Hypercholesterolemia | P3 | Completed | 1,053 | RCT, Double-blind | ezetimibe and atorvastatin, atorvastatin, Placebo (unspecified) |
| NCT01208207 A Two-Part 26-Week Study of Etoricoxib as Treatment for Ankylosing Spondylitis (AS) (MK-0663-108) | Spondylitis, Ankylosing | P3 | Completed | 1,015 | RCT, Double-blind | Part I - etoricoxib 60 mg, Part I - etoricoxib 90 mg, Part I- naproxen 1000 mg, Part I - Placebo to naproxen 500 mg, Part II- etoricoxib 60 mg, Part II- etoricoxib 90 mg, Part II- naproxen 1000 mg, Part I - Placebo to etoricoxib 60 mg, Part I - Placebo to etoricoxib 90 mg, Part II- Placebo to etoricoxib 60 mg, Part II - Placebo to etoricoxib 90 mg, Part II- Placebo to naproxen 500 mg |
| NCT01918033 A Study of the Efficacy and Safety of Desloratadine (MK-4117) in Japanese Participants With Perennial Allergic Rhinitis (MK-4117-200) | Perennial Allergic Rhinitis | P3 | Completed | 608 | RCT, Double-blind | Desloratadine 5 mg, Placebo |
| NCT00090259 Study to Evaluate Potential Decrease in Hospitalization Events, Time Between Events, and Increasing Longevity in Patients With Symptomatic Heart Failure (0954-948) | Heart Failure | P3 | Completed | 3,834 | RCT, Double-blind | Losartan 50 mg, Losartan 150 mg |
| NCT03882996 A Long-term Safety and Tolerability Study of Ezetimibe Plus Atorvastatin in Participants With Coronary Heart Disease, Multiple Risk Factors, or Hypercholesterolemia Not Controlled by Atorvastatin (P01418/MK-0653-032) | Hypercholesterolemia | P3 | Completed | 432 | Open-label | Ezetimibe, Atorvastatin |
| NCT01165424 A Study of Long-term Administration of Mometasone Furoate Nasal Spray in Pediatric Subjects With Perennial Allergic Rhinitis (Study P06333AM1) | Rhinitis, Allergic, Perennial | P3 | Completed | 80 | Open-label | mometasone furoate |
| NCT00899379 Treatment of Multiple Attacks of Acute Migraine (0462-025) | Migraine Headache | P3 | Completed | 473 | RCT, Double-blind | rizatriptan benzoate, Comparator: Placebo |
| NCT03983980 Tapinarof for the Treatment of Plaque Psoriasis in Adults (3002) | Plaque Psoriasis | P3 | Completed | 515 | RCT, Double-blind | Tapinarof, Vehicle Cream |
| NCT00383552 Effects of Mometasone Furoate/Formoterol Combination Versus Mometasone Furoate Alone in Persistent Asthmatics (Study P04073AM1)(COMPLETED) | Asthma | P3 | Completed | 746 | RCT, Double-blind | Mometasone Furoate/Formoterol Fumarate Combination MDI 100/10 mcg BID, Mometasone Furoate MDI (MF MDI), Formoterol Fumarate 10 mcg, Placebo |
| NCT00092014 A Study to Evaluate and Compare Alendronate and Risedronate on Bone Mineral Density in Women With Postmenopausal Osteoporosis (MK-0217-211) | Postmenopausal Osteoporosis | P3 | Completed | 1,053 | RCT, Double-blind | Alendronate, Risedronate 35 mg, Risendronate placebo, Alendronate placebo |
| NCT00408863 Livial Intervention Following Breast Cancer; Efficacy, Recurrence and Tolerability Endpoints (LIBERATE)(COMPLETED)(P05885) | Breast Cancer, Climacteric Symptoms | P3 | Completed | 3,148 | RCT, Double-blind | tibolone, placebo |
| NCT00092040 A Study and 12 Month Extension to Evaluate Two Investigational Drugs in Postmenopausal Women With Osteoporosis (MK-0217-907) | Osteoporosis, Postmenopausal | P3 | Completed | 936 | RCT, Double-blind | MK0217, alendronate sodium/Duration of Intervention: 12 mo, Comparator: risedronate / Duration of Intervention: 12 mo |
| NCT00400218 Evaluate the Safety and Anti-Hypertensive Efficacy of Hyzaar(R) In Patients With Mild To Moderate Essential Hypertension (0954A-323) | Hypertension | P3 | Completed | 62 | Open-label | MK0954A, hydrochlorothiazide (+) losartan potassium / Duration of Treatment: 12 Weeks |
| NCT00817076 Study of the Effectiveness and Safety of Desloratadine (Aerius) Syrup in Children With Allergic Skin Inflammation (P03475) | Dermatitis, Atopic | P3 | Completed | 40 | Open-label | desloratadine |
| NCT00546052 A 52 Week Study to Evaluate the Effects of Losartan With or Without HCTZ on Plasma Glucose, Metabolic Parameters, Blood Pressure in Hypertensive Patients With Metabolic Syndrome (0954A-331) | Hypertension, Metabolic Disorder | P3 | Completed | 1,738 | Open-label | losartan potassium (+) hydrochlorothiazide |
| NCT00805324 Study of the Effectiveness and Safety of Desloratadine (Aerius) Syrup in Children With Hayfever With or Without Asthma (P03472) | Rhinitis, Allergic, Seasonal, Asthma | P3 | Completed | 54 | Open-label | Desloratadine |
| NCT00092118 The Clinical Effects of Montelukast in Patients With Perennial Allergic Rhinitis (0476-265) | Rhinitis, Allergic, Perennial | P3 | Completed | 1,992 | RCT, Double-blind | Montelukast, Comparator: Placebo |
| NCT03855189 Safety and Efficacy of Mometasone Furoate (SCH 032088) vs Beclomethasone Dipropionate or Placebo in Seasonal Allergic Rhinitis (C93-013) | Seasonal Allergic Rhinitis | P3 | Completed | 345 | RCT, Double-blind | Mometasone Furoate (MF), Beclomethasone Dipropionate (BDP), Placebo |
| NCT00271817 To Evaluate Ezetimibe/Simvastatin and Niacin (Extended Release Tablet) in Patients With Type IIa or Type IIb Hyperlipidemia (0653A-091)(COMPLETED) | Hypercholesterolemia | P3 | Completed | 1,220 | RCT, Double-blind | Comparator: ezetimibe/simvastatin + niacin (ER), Comparator: Placebo to ezetimibe/simvastatin, Comparator: niacin (ER) tablet, Comparator: ezetimibe (+) simvastatin, Comparator: Placebo to Niacin (ER), Comparator: ezetimibe/simvastatin and niacin (ER), Comparator: ezetimibe and simvastatin, Comparator: Placebo to niacin (ER) |
| NCT00378378 Study of Nasonex® for the Treatment of Nasal Polyps in Pediatric Subjects Between Ages of 6 and Less Than 18 Years Old (P04292) | Nasal Polyps | P3 | Completed | 127 | RCT, Double-blind | Mometasone Furoate Nasal Spray (MFNS), Placebo nasal spray |
| NCT00398606 A Study to Compare the Efficacy of Alendronate With and Without Calcium or Calcium Alone In the Treatment of Osteoporosis in Postmenopausal Women (0217-088)(COMPLETED) | Osteoporosis, Postmenopausal | P3 | Completed | 650 | RCT, Double-blind | MK0217, alendronate sodium / Duration of Treatment : 2 Years, Comparator : calcium carbonate /Duration of Treatment : 2 Years |
| NCT00897104 MK0462 5 mg, Sumatriptan 50 mg, and Placebo Comparison Study (0462-029) | Migraine Headache | P3 | Completed | 933 | RCT, Double-blind | rizatriptan benzoate (MK0462), Comparator: sumatriptan, Comparator: Placebo |
| NCT00092638 An Investigational Drug Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-804)(COMPLETED) | Hypercholesterolemia, Coronary Disease | P3 | Completed | 450 | RCT, Double-blind | MK0653, ezetimibe, Comparator: ezetimibe, placebo |
| NCT02550288 A Clinical Trial to Assess the Efficacy and Safety of MK-0653C in Japanese Participants With Hypercholesterolemia (MK-0653C-383) | Hypercholesterolemia | P3 | Completed | 309 | RCT, Double-blind | Ezetimibe 10 mg, Atorvastatin 10 mg, Placebo for Ezetimibe 10 mg tablet, Placebo for Atorvastatin 10 mg capsule |
| NCT00651560 Vytorin As Strategy To Reduce Dislipidemia In Adults (0653A-148) | Hyperlipidemia | P3 | Completed | 167 | Open-label | ezetimibe (+) simvastatin |
| NCT01349907 Extension Study of Asenapine [P06107 (NCT01244815)] for Pediatric Bipolar Disorder (P05898) | Bipolar Disorder | P3 | Completed | 322 | Open-label | Asenapine, Rescue medication |
| NCT00751075 Effectiveness and Safety of Once or Twice Daily Mometasone Nasal Spray Versus Amoxicillin Versus Placebo for Treatment of Acute Rhinosinusitis (Phase 3 Study)(Study P02692) | Acute Rhinosinusitis | P3 | Completed | 981 | RCT, Double-blind | mometasone furoate nasal spray (MFNS), MFNS, Amoxicillin, Placebo |
| NCT00092755 An Investigational Drug in Patients With Osteoarthritis (0663-073) | Osteoarthritis | P3 | Completed | 548 | RCT, Double-blind | MK0663, etoricoxib, Comparators: ibuprofen and placebo |
| NCT01026870 Efficacy and Safety of Mometasone Furoate for Persistent Asthma Previously Treated With Low-Dose Inhaled Glucocorticosteroids (ICS) (Study P06115) | Asthma | P3 | Withdrawn | — | RCT, Double-blind | SCH 32088 mometasone furoate (MF) metered-dose inhaler, Placebo metered-dose inhaler BID |
| NCT00389896 A Crossover Study to Evaluate the Efficacy of Simvastatin in Elevating HDL-C Levels in Patients With Type 2 Diabetes (0733-216)(COMPLETED) | HDL Cholesterol | P3 | Completed | 150 | RCT, Double-blind | MK0733 / Duration of Treatment: 18 Weeks, Comparator: placebo (unspecified) / Duration of Treatment: 18 Weeks |
| NCT00620464 A Bioequivalence Study of IMPLANON and Radiopaque IMPLANON (34528)(P05720) | Contraception | P3 | Completed | 108 | RCT, Double-blind | Radiopaque Implanon, Implanon (etonogestrel implant) |
| NCT00092807 Sitosterolemia Extension Study (0653-003)(COMPLETED) | Lipid Metabolism, Inborn Errors, Heart Disease | P3 | Completed | 37 | — | MK0653, ezetimibe, Comparator: placebo |
| NCT01135134 Multicenter, Double-blind, Randomized, Placebo-controlled Study of Mometasone Furoate Nasal Spray in Pediatric Subjects With Perennial Allergic Rhinitis (Study P06332) | Rhinitis, Allergic, Perennial | P3 | Completed | 333 | RCT, Double-blind | Mometasone furoate, Placebo |
| NCT00092027 A Study to Evaluate the Safety and Tolerability of MK0217 in Women (0217-219) | Postmenopausal Osteoporosis | P3 | Completed | 454 | RCT, Double-blind | MK0217, alendronate sodium/Duration of Treatment: 6 months, Comparator: placebo / Duration of Treatment: 6 months |
| NCT00151424 Efficacy and Safety of Asenapine With Placebo and Olanzapine (41022)(P05947) | Schizophrenia | P3 | Completed | 277 | RCT, Double-blind | asenapine, Placebo, Olanzapine |
| NCT00229970 MK0476 Study in Adult Patients With Acute Asthma (0476-322) | Asthma | P3 | Completed | 225 | RCT, Double-blind | montelukast sodium, Comparator: Placebo |
| NCT00757562 Safety of Desloratadine in Children With Allergy Sensitivity and Chronic Hives, Who Are Poor Metabolizers of Desloratadine (Study P02994) | Chronic Idiopathic Urticaria, Atopy | P3 | Completed | 97 | RCT, Double-blind | desloratadine, Placebo |
| NCT00092898 An Investigational Drug Study to Lower Non-Cholesterol Sterol Levels Associated With Sitosterolemia (0653-062)(COMPLETED) | Lipid Metabolism, Inborn Errors, Heart Disease | P3 | Completed | 30 | RCT, Double-blind | MK0653, ezetimibe, Comparator: placebo |
| NCT01857063 Study of the Efficacy and Safety of MK-0476 in Japanese Pediatric Participants With Seasonal Allergic Rhinitis (MK-0476-519) | Seasonal Allergic Rhinitis | P3 | Completed | 220 | RCT, Double-blind | Montelukast, Placebo |
| NCT00862251 Ezetimibe/Simvastatin (MK-0653A) Versus Rosuvastatin Versus Doubling Statin Dose in Participants With Cardiovascular Disease and Diabetes Mellitus (MK-0653A-133)(COMPLETED) | Cardiovascular Disorder, Diabetes Mellitus | P3 | Completed | 808 | RCT, Double-blind | ezetimibe (+) simvastatin, simvastatin 40 mg or atorvastatin 20 mg, Rosuvastatin, atorvastatin 10 mg or simvastatin 20 mg |
| NCT00250458 Study to Test a Marketed Product in the Treatment of Migraine-associated Nausea | Migraine | P3 | Completed | 346 | RCT, Double-blind | Comparator: Rizatriptan, Comparator: Placebo |
| NCT00092742 Investigational Drug Versus an Approved Drug in Patients With Rheumatoid Arthritis (0663-072) | Rheumatoid Arthritis | P3 | Completed | 4,086 | RCT, Double-blind | MK0663, etoricoxib, Comparator: Diclofenac sodium |
| NCT02524288 Efficacy and Safety of Etonogestrel + 17β-Estradiol Vaginal Ring in Women at Risk for Pregnancy (MK-8342B-061) | Contraception | P3 | Terminated | 1,941 | Open-label | ENG-E2 125 μg/300 μg vaginal ring |
| NCT00405964 Study for the Treatment of Persistent Allergic Rhinitis With Desloratadine (Study P04684) | Allergic Rhinitis | P3 | Completed | 716 | RCT, Double-blind | 5-mg Desloratadine, Placebo tablet |
| NCT00700661 A Study of MK0476 in the Treatment of Asthma Patients Aged 2-5 Years (0476-907) | Asthma | P3 | Completed | 500 | RCT, Double-blind | montelukast, placebo (unspecified) |
| NCT00480662 A Research Study to Test the Effectiveness of MK0217 in Patients With Paget's Bone Disease (0217-206)(COMPLETED) | Paget's Disease of Bone | P3 | Completed | 60 | RCT, Double-blind | alendronate |
| NCT00552097 Effect of Ezetimibe Plus Simvastatin Versus Simvastatin Alone on Atherosclerosis in the Carotid Artery (ENHANCE)(P02578) | Atherosclerosis, Hypercholesterolemia | P3 | Completed | 720 | RCT, Double-blind | ezetimibe (plus simvastatin), placebo (plus simvastatin) |
| NCT01190267 Flexible Dose, Long-term Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05897) | Schizophrenia, Paranoid, Schizophrenia, Disorganized | P3 | Completed | 204 | Open-label | asenapine |
| NCT00393354 Effect of Etoricoxib to Treat Chronic Low Back Pain (0663-041) | Recurrent Low Back Pain | P3 | Completed | 325 | RCT, Double-blind | MK0663, Etoricoxib / Duration of Treatment : 12 Weeks, Comparator : placebo (unspecified) /Duration of Treatment : 12 Weeks |
| NCT00328523 TWICE (Ezetimibe Together With Any Statin Cholesterol Enhancement)(0653-060) | Hypercholesterolaemia, Hyperlipidaemia | P3 | Completed | 1,496 | RCT, Open-label | MK-0653, ezetimibe, Duration of Treatment: 3 months |
| NCT00245570 Montelukast Compared With Placebo and Salmeterol in Exercise-Induced Bronchoconstriction (0476-316) | Asthma, Exercise-Induced | P3 | Completed | 47 | RCT, Double-blind | Comparator: Montelukast, Comparator: Salmeterol, Comparator: Placebo (montelukast), Comparator: Placebo (salmeterol) |
| NCT03867110 An Efficacy and Safety Study of Ezetimibe (MK-0653, SCH 58235) in Addition to Atorvastatin Compared to Placebo in Participants With Primary Hypercholesterolemia (MK-0653-013) | Hypercholesterolemia | P3 | Completed | 628 | RCT, Double-blind | Placebo, Ezetimibe 10 mg, Atorvastatin 10 mg, Atorvastatin 20 mg, Atorvastatin 40 mg, Atorvastatin 80 mg |
| NCT01142596 Long-term Extension Trial of Asenapine in Subjects With Schizophrenia (Study P06125) | Schizophrenia | P3 | Completed | 201 | RCT, Double-blind | Asenapine, Placebo |
| NCT00653523 Coadministration of Ezetimibe and Simvastatin in Patients With Primary Hypercholesterolemia (P05457) | Hypercholesterolemia | P3 | Completed | 151 | Open-label | Ezetimibe, Simvastatin |
| NCT00817817 A Study to Determine the Efficacy and Safety of Two Mometasone Dry Powder Inhalers in the Treatment of Asthma (Study P02524) | Asthma | P3 | Completed | 93 | RCT, Open-label | — |
| NCT00092781 A Study of MK0663 and an Approved Drug in the Treatment of Osteoarthritis (0663-077)(COMPLETED) | Osteoarthritis | P3 | Completed | 500 | RCT, Double-blind | MK0663, etoricoxib, Comparator: celecoxib |
| NCT00381485 Effects of Mometasone Furoate/Formoterol Combination Versus Mometasone Furoate Alone in Persistent Asthmatics (Study P04431AM2)(COMPLETED) | Asthma | P3 | Completed | 834 | RCT, Double-blind | Mometasone furoate/formoterol (MF/F) combination, Mometasone furoate/formoterol (MF/F) combination, Mometasone furoate MDI (MF MDI) |
| NCT00462748 A Study to Determine the Number of Patients Who Reach Optimal Cholesterol Levels on Each of Three Different Treatments (0653A-121) | Hypercholesterolemia | P3 | Completed | 786 | RCT, Double-blind | ezetimibe (+) simvastatin, Comparator: atorvastatin, Comparator: rosuvastatin |
| NCT00276484 To Evaluate Ezetimibe Plus Atorvastatin Versus Atorvastatin in Patients With High Cholesterol Not Controlled on Atorvastatin 40 mg (0653-090) | Hypercholesterolemia | P3 | Completed | 579 | RCT, Double-blind | atorvastatin, atorvastatin, ezetimibe |
| NCT00756938 Study of Losartan in Pediatric Patients With Hypertension (MK-0954-337) | Hypertension | P3 | Completed | 101 | RCT, Open-label | losartan potassium |
| NCT00783263 A Study of Ezetimibe Added On to Rosuvastatin Versus Up Titration of Rosuvastatin in Patients With Hypercholesterolemia (MK0653-139) | Hypercholesterolemia | P3 | Completed | 440 | RCT, Double-blind | Comparator: rosuvastatin 5 mg + ezetimibe 10 mg, Comparator: rosuvastatin 10 mg, Comparator: rosuvastatin 10 mg + ezetimibe 10 mg, Comparator: rosuvastatin 20 mg |
| NCT00281320 Study of Asenapine in Elderly Subjects With Psychosis (A7501021)(P05717) | Psychosis | P3 | Completed | 122 | RCT, Double-blind | Asenapine |
| NCT00092768 A Study of MK0663 and an Approved Drug in the Treatment of Osteoarthritis (0663-076)(COMPLETED) | Osteoarthritis | P3 | Completed | 500 | RCT, Double-blind | MK0663, etoricoxib, Comparator: celecoxib |
| NCT00725374 A Study to Investigate the Effects of Tibolone (Livial®) on Breast Tissue in Postmenopausal Women With Breast Cancer (Study 32971)(P06469) | Breast Cancer | P3 | Completed | 102 | RCT, Double-blind | tibolone, placebo |
| NCT00692913 A Study to Test the Effect of MK0217A on Vitamin D Inadequacy in Postmenopausal Women With Osteoporosis (0217A-262) | Osteoporosis | P3 | Completed | 515 | RCT, Open-label | FOSAVANCE 5600 (Alendronate Sodium (+) cholecalciferol) |
| NCT01617187 A Study of the Efficacy and Safety of Asenapine in Participants With an Acute Exacerbation of Schizophrenia (P05688) | Schizophrenia | P3 | Completed | 360 | RCT, Double-blind | Asenapine, Placebo Asenapine, Olanzapine, Placebo Olanzapine |
| NCT04053387 Long Term Extension Study of Tapinarof for Plaque Psoriasis in Adults (3003) | Plaque Psoriasis | P3 | Completed | 763 | Open-label | tapinarof cream, 1% |
| NCT00092885 An Approved Drug to Study a New Indication for Seasonal Allergic Rhinitis in Patients With Asthma (0476-269) | Rhinitis, Allergic, Seasonal, Asthma, Bronchial | P3 | Completed | 831 | RCT, Double-blind | MK0476, montelukast sodium, Comparator: placebo |
| NCT00284856 Montelukast Asthmatic Smoker Study (0476-332)(COMPLETED) | Asthma | P3 | Completed | 1,640 | RCT, Double-blind | montelukast sodium, Comparator: Placebo, Comparator: fluticasone, Comparator: Placebo |
| NCT00652301 A Research Study to Evaluate MK0653 (Ezetimibe) and Simvastatin, Given Together and Alone, on Intestinal Absorption of Cholesterol (0653-050)(COMPLETED) | Cholesterol | P3 | Completed | 40 | RCT, Double-blind | ezetimibe, Comparator: Placebo (unspecified), simvastatin |
| NCT00250445 A Study to Evaluate the Safety of an Investigational Drug (Etoricoxib) in Patients With Osteoarthritis (OA) or Rheumatoid Arthritis (RA)(0663-066) | Rheumatoid Arthritis,Osteoarthritis | P3 | Completed | 23,498 | RCT, Double-blind | MK0663, etoricoxib, Comparator: Diclofenac sodium |
| NCT02748057 A Clinical Trial to Assess the Long Term Safety and Tolerability of MK-0653H in Japanese Participants With Hypercholesterolemia (MK-0653H-833) | Hypercholesterolemia, Familial Hypercholesterolemia | P3 | Completed | 135 | RCT, Open-label | Ezetimibe, Rosuvastatin |
| NCT00457275 Observational Study to Evaluate LDL-C Lowering Effect of Ezetimibe (0653-070) | Hypercholesterolemia | P3 | Completed | 440 | RCT, Open-label | MK0653, ezetimibe / Duration of Treatment: 4 Weeks |
| NCT01004263 A Study to Evaluate the Safety and Tolerability of Rizatriptan for Long Term Treatment of Acute Migraine in Children and Adolescents (MK-0462-086 AM3) | Acute Migraine With or Without Aura in Adolescents | P3 | Completed | 674 | Open-label | rizatriptan benzoate |
| NCT00092833 Investigational Drug in Patients With Hypercholesterolemia or in Patients With Sitosterolemia (0653-026)(COMPLETED) | Hypercholesterolemia, Familial, Lipid Metabolism, Inborn Errors | P3 | Terminated | 49 | Open-label | Comparator: ezetimibe |
| NCT00092963 Study to Test an Approved Product in the Early Treatment of Migraine (0462-065) | Migraine | P3 | Completed | 529 | RCT, Double-blind | MK0462, rizatriptan benzoate / Duration of Treatment: 1day, Comparator: placebo / Duration of Treatment: 1 day |
| NCT00442338 Study of MK-0476 in Adult Patients With Acute Asthma (0476-334) | Asthma | P3 | Completed | 91 | RCT, Open-label | montelukast sodium, montelukast sodium, aminophylline hydrate |
| NCT00511199 Efficacy and Safety of the Combined Oral Contraceptive (COC) NOMAC-E2 Compared to a COC Containing DRSP/EE (292001)(COMPLETED)(P05724) | Contraception | P3 | Completed | 2,152 | RCT, Open-label | NOMAC-E2, DRSP-EE |
| NCT01656434 Study of the Contraceptive Efficacy and Safety of a NOMAC-E2 Combined Oral Contraceptive (COC)(P06448) | Contraception | P3 | Terminated | 3,173 | RCT, Open-label | NOMAC-E2, NETA-EE, ethinylestradiol (EE), ferrous fumarate |
| NCT00092105 Study of MK0476 (Montelukast Sodium) and Effects on Asthma and Nasal Symptoms Upon Exposure to Cats (0476-256) | Asthma, Bronchial, Rhinitis, Allergic, Perennial | P3 | Completed | 58 | RCT, Double-blind | MK0476, montelukast sodium, Comparator: placebo |
| NCT00423995 Effect of Loratadine/Montelukast Combination on Congestion in SAR Patients Exposed to Pollen in an EEU (Study P04822) | Seasonal Allergic Rhinitis | P3 | Completed | 379 | RCT, Double-blind | Loratadine/montelukast combination |
| NCT00395473 Ezetimibe Added to Statin Therapy (EASY) Study (0653-087)(COMPLETED) | Hypercholesterolemia | P3 | Completed | 141 | Open-label | MK0653, ezetimibe / Duration of Treatment: 6 Weeks |
| NCT00968201 Chronic Asthma Study in 2- to 5-Year-Old Patients (MK0476-072 ) | Asthma | P3 | Completed | 689 | RCT, Double-blind | montelukast sodium, Comparator: Placebo |
| NCT00468312 Placebo-Controlled Study of Mometasone Furoate Nasal Spray (MFNS) 200 mcg QD in the Treatment of Seasonal Allergic Rhinitis (Study P05106)(COMPLETED) | Seasonal Allergic Rhinitis | P3 | Completed | 429 | RCT, Double-blind | Mometasone furoate nasal spray, Placebo |
| NCT04626596 A Study to Assess Contraceptive Efficacy and Safety of Etonogestrel (ENG) Implant Beyond 3 Years of Use (MK-8415-060) | Contraception | P3 | Completed | 498 | Open-label | — |
| NCT05142774 Long Term Extension Study of Tapinarof Cream, 1% for Subjects With Atopic Dermatitis | Atopic Dermatitis | P3 | Completed | 728 | Open-label | Tapinarof cream, 1% |
| NCT00779740 Equivalency Study of Two Formulations of Mometasone Furoate Nasal Spray (Study P04419) | Rhinitis, Allergic, Perennial | P3 | Completed | 102 | RCT, Open-label | mometasone furoate, mometasone furoate |
| NCT00897949 MK0462 in Treatment of Migraine With Recurrence (MK0462-022) | Migraine Headache | P3 | Completed | 1,473 | RCT, Double-blind | rizatriptan benzoate (MK0462), Comparator: placebo |
| NCT00089895 EARLY ACS: Early Glycoprotein IIb/IIIa Inhibition in Patients With Non-ST-segment Elevation Acute Coronary Syndrome (Study P03684AM2)(COMPLETED) | Myocardial Ischemia, Acute Coronary Syndrome | P3 | Completed | 9,406 | RCT, Double-blind | Eptifibatide (Integrilin), Placebo |
| NCT00568178 An Extension Study Designed to Assess Effects of Losartan on Proteinuria in Pediatric Populations (MK-0954-326 AM1,EXT1(AM2)) | Proteinuria | P3 | Completed | 306 | RCT, Double-blind | Losartan Potassium, Comparator: amlodipine besylate, Enalapril Maleate |
| NCT00383435 Effects of Mometasone Furoate/Formoterol Combination Versus Formoterol and Mometasone Furoate Alone in COPD (Study P04229AM4)(COMPLETED) | Chronic Obstructive Pulmonary Disease (COPD) | P3 | Completed | 1,055 | RCT, Double-blind | Mometasone furoate/formoterol (MF/F) combination, Mometasone furoate/formoterol (MF/F) combination, Mometasone furoate MDI (MF MDI), Formoterol MDI, Placebo |
| NCT03884452 Ezetimibe (SCH 58235) Taken With Either Atorvastatin or Simvastatin in Participants With Familial Hypercholesterolemia (MK-0653-018) | Familial Hypercholesterolemia | P3 | Completed | 50 | RCT, Double-blind | Atorvastatin, Simvastatin, Ezetimibe, Placebo for Ezetimibe |
| NCT00795158 How Desloratadine (Clarinex, Aerius) Affects Quality of Life in Patients With Chronic Idiopathic Urticaria (Have Had Hives for 6 Weeks or Longer)(Study P02988) | Urticaria | P3 | Completed | 282 | Open-label | desloratadine |
| NCT00511355 Effects on Hemostasis, Lipids, Carbohydrate Metabolism, Adrenal & Thyroid Function of the Combined Oral Contraceptive NOMAC-E2 Compared to a COC Containing LNG-EE (292004)(COMPLETED)(P05764) | Contraception | P3 | Completed | 121 | RCT, Open-label | NOMAC-E2, Levonorgestrel and Ethinyl Estradiol |
| NCT00620035 A Multicenter Trial to Evaluate the Insertion Characteristics of the Radiopaque Etonogestrel Implant Using a Next Generation Applicator (34530)(P05702) | Contraception | P3 | Completed | 301 | Open-label | Radiopaque Etonogestrel Implant |
| NCT01144416 Efficacy and Safety Study of a Single Injection of SCH 900962 Versus Daily recFSH Injections in Women Undergoing Controlled Ovarian Stimulation (Study P06029) | Infertility | P3 | Completed | 1,424 | RCT, Double-blind | SCH 900962 / Corifollitropin alfa / Org 36286, RecFSH / follitropin beta, Placebo for SCH 900962, Placebo for recFSH |
| NCT00696878 Corifollitropin Alfa in Participants Undergoing Repeated Controlled Ovarian Stimulation (COS) Cycles Using a Multiple Dose Gonadatropin Releasing Hormone (GnRH) Antagonist Protocol (Study 38825)(P05714) | In Vitro Fertilization | P3 | Completed | 682 | Open-label | Corifollitropin alfa, FSH, GnRH antagonist, (rec)hCG, Progesterone |
| NCT00453063 Placebo-Controlled Study of Mometasone Furoate Nasal Spray (MFNS) 200 mcg Once Daily (QD) in the Treatment of Seasonal Allergic Rhinitis (Study P05067)(COMPLETED) | Seasonal Allergic Rhinitis | P3 | Completed | 426 | RCT, Double-blind | mometasone furoate, Placebo |
| NCT00159744 3-Week Study of Asenapine, Olanzapine and Placebo for Treatment of Bipolar Mania (P07008) | Bipolar Disorder | P3 | Completed | 488 | RCT, Double-blind | Asenapine, Olanzapine, Placebo |
| NCT00650819 Comparison of Ezetimibe Plus Simvastatin Versus Ezetimibe or Simvastatin Alone in Subjects With Primary Hypercholesterolemia (Study P03757)(COMPLETED) | Hypercholesterolemia | P3 | Completed | 240 | RCT, Double-blind | Ezetimibe + Simvastatin, Simvastatin, Ezetimibe |
| NCT03882892 Long-Term Safety and Tolerability of Ezetimibe (SCH 58235, MK-0653) With Atovastatin (P02154, MK-0653-017) | Hypercholesterolemia | P3 | Completed | 400 | RCT, Double-blind | Ezetimibe, Atovastatin, Placebo |
| NCT00092664 An Extension Study of An Investigational Drug in Patients With Hypercholesterolemia (0653A-038)(COMPLETED) | Hypercholesterolemia | P3 | Completed | 1,104 | RCT, Double-blind | MK0653A, ezetimibe (+) simvastatin / Duration of Treatment: 14 weeks |
| NCT00552032 Efficacy and Safety of Mometasone Furoate Nasal Spray in Children With Adenoid Hypertrophy. SNORE Study (P05155) | Adenoids Hypertrophy | P3 | Completed | 132 | RCT, Double-blind | Mometasone Furoate nasal spray, Placebo |
| NCT03956355 Tapinarof for the Treatment of Plaque Psoriasis in Adults (3001) | Plaque Psoriasis | P3 | Completed | 510 | RCT, Double-blind | Tapinarof, Vehicle Cream |
| NCT00461032 Montelukast Back to School Asthma Study (0476-340) | Asthma | P3 | Completed | 1,162 | RCT, Double-blind | montelukast, Comparator: Placebo |
| NCT01554163 Safety and Efficacy of Etoricoxib 30 mg Versus Celecoxib 200 mg in Korean Participants With Osteoarthritis | Osteoarthritis of the Knee | P3 | Completed | 239 | RCT, Double-blind | Etoricoxib 30 mg, Celecoxib 200 mg |
| NCT00911547 The Clinical Effect of MK0476 With Concomitant Administration of and Removal of Inhaled Beclomethasone in Asthmatic Patients (0476-029) | Asthma | P3 | Completed | 642 | RCT, Double-blind | montelukast sodium, beclomethasone, Placebo inhaler, placebo tablet |
| NCT00212784 Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25517)(P05935) | Schizophrenia, Schizoaffective Disorder | P3 | Completed | 1,225 | RCT, Double-blind | asenapine, olanzapine |
| NCT00496730 A Multicenter, Randomized, Open Label Study to Evaluate the Lipid Lowering Efficacy and Safety of Vytorin® 10/20 vs. Atorvastatin 10mg in Hypercholesterolemia Patients With Metabolic Syndrome in Korea (0653A-129)(COMPLETED) | Hypercholesterolemia | P3 | Completed | 256 | RCT, Open-label | simvastatin (+) ezetimibe, Comparator: atorvastatin |
| NCT02320396 Efficacy and Safety Study of Desloratadine (MK-4117) in Japanese Participants With Seasonal Allergic Rhinitis (MK-4117-204) | Seasonal Allergic Rhinitis | P3 | Completed | 449 | RCT, Double-blind | Desloratadine 5 mg, Placebo |
| NCT00541697 Eze/Simva Switch Study in Diabetics (0653A-807) | Diabetes Mellitus, Type 2 | P3 | Completed | 648 | RCT, Double-blind | MK0653A, ezetimibe (+) simvastatin / Duration of Treatment: 6 Weeks, Comparator: atorvastatin / Duration of Treatment: 6 Weeks |
| NCT00145470 12 Week Study of the Safety/Efficacy of Asenapine When Added to Lithium/Valproate in the Treatment of Bipolar Disorder (A7501008 / P05844 / MK-8274-017) | Bipolar Disorder | P3 | Completed | 326 | RCT, Double-blind | Asenapine, Placebo |
| NCT00972738 Montelukast in Seasonal Allergic Rhinitis - Spring 2001 Study (0476-235) | Seasonal Allergic Rhinitis | P3 | Completed | 1,214 | RCT, Double-blind | montelukast sodium, Comparator: loratadine, Comparator: Placebo |
| NCT00145496 Efficacy and Safety of Asenapine Compared With Olanzapine in Patients With Persistent Negative Symptoms of Schizophrenia (A7501013)(COMPLETED)(P05771) | Schizophrenia | P3 | Completed | 468 | RCT, Double-blind | Asenapine, Olanzapine |
| NCT00202878 IMPROVE-IT: Examining Outcomes in Subjects With Acute Coronary Syndrome: Vytorin (Ezetimibe/Simvastatin) vs Simvastatin (P04103) | Hypercholesterolemia, Myocardial Infarction | P3 | Completed | 18,144 | RCT, Double-blind | ezetimibe/simvastatin, simvastatin, Placebo for simvastatin 40 mg, Placebo for ezetimibe 10 mg/simvastatin 40 mg combination |
| NCT00092625 Co-administration Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-803) | Hypercholesterolemia, Coronary Disease | P3 | Completed | 442 | RCT, Double-blind | MK0653, ezetimibe, Comparator: ezetimibe, placebo |
| NCT00143182 9 Week Extension Study of Asenapine and Olanzapine in Treatment of Mania (P07007)(COMPLETED) | Bipolar Disorder | P3 | Completed | 504 | Double-blind | Asenapine, Olanzapine |
| NCT00511342 Effects on Bone Mineral Density (BMD) of the Combined Oral Contraceptive NOMAC-E2 Compared to a COC Containing LNG/EE (292005)(P05765)(COMPLETED) | Contraception | P3 | Completed | 110 | RCT, Open-label | NOMAC-E2, LNG-EE |
| NCT00702845 To Investigate Efficacy and Safety of a Single Injection of Org 36286 for Ovarian Stimulation Using Daily Recombinant FSH as Reference (Ensure)(P05690/MK-8962-001) | Infertility | P3 | Completed | 397 | RCT, Double-blind | corifollitropin alfa (Org 36286), recFSH (follitropin beta), gonadatropin releasing hormone (GnRH) antagonist (ganirelix), human chorion gonadatropin (hCG), progesterone, placebo-recFSH (follitropin alfa), placebo-corifollitropin alfa, open-label recFSH |
| NCT00092586 Study of an Approved Drug With a Statin (a Medication That Lowers Cholesterol Levels) as Compared to Statin Therapy Alone in Patients With High Cholesterol (0653-040) | Hypercholesterolemia | P3 | Completed | 2,904 | RCT, Double-blind | MK0653, ezetimibe, Comparator: statins |
| NCT00127179 A Study of an Investigational Study Drug for Benign Prostatic Hyperplasia (0906-140) | Benign Prostatic Hyperplasia | P3 | Completed | 600 | RCT, Double-blind | MK0906, finasteride / Duration of Treatment: 48 weeks, Comparator: placebo / Duration of Treatment: 48 weeks |
| NCT00337675 Intermittent and Daily Dosing for Episodic (Periodic) Asthma (0476-302)(COMPLETED) | Asthma | P3 | Completed | 1,771 | RCT, Double-blind | montelukast sodium, Comparator: Placebo (unspecified), montelukast sodium |
| NCT03855228 Safety and Efficacy of Mometasone Furoate Nasal Spray With the Addition of Loratadine Versus Placebo in Participants With Seasonal Allergic Rhinitis (C94-145) | Rhinitis, Allergic | P3 | Completed | 704 | RCT, Double-blind | Mometasone furoate nasal spray (MFNS), Loratadine, Placebo nasal spray, Placebo tablet |
| NCT00156065 Long-Term Efficacy and Safety of Asenapine Using Haloperidol as a Positive Control (41513)(COMPLETED)(P05785) | Schizophrenia | P3 | Completed | 187 | RCT, Double-blind | Haloperidol, Asenapine, Asenapine |
| NCT00867165 Pediatric Study to Evaluate the Efficacy and Safety of Ezetimibe Monotherapy in Children With Primary Hypercholesterolemia (P05522) | Primary Hypercholesterolemia | P3 | Completed | 138 | RCT, Double-blind | ezetimibe, Placebo |
| NCT03882047 Mometasone Furoate Aqueous (MK-0887/SCH 032088) Nasal Spray vs Placebo and FLONASE® in Seasonal Allergic Rhinitis Patients (I94-001) | Rhinitis, Allergic, Seasonal | P3 | Completed | 313 | RCT, Double-blind | Mometasone furoate, Fluticasone propionate, Mometasone furoate placebo, Fluticasone propionate placebo |
| NCT00092209 Antihypertensive Efficacy and Safety of Approved Drugs in Japanese Patients With Essential Hypertension (Banyu Study)(0954A-302) | Hypertension | P3 | Completed | 840 | RCT, Double-blind | MK0954A, hydrochlorothiazide (+) losartan potassium, Comparator: placebo, losartan, hydrochlorothiazide |
| NCT00424008 Study of Inhaled Glucocorticosteroids/Long-Acting Bronchodilator Drugs in Subjects With Asthma That Have Been Taking Inhaled Glucocorticosteroids (Study P04705AM1) | Asthma | P3 | Completed | 722 | RCT, Single-blind | Mometasone furoate/formoterol (MF/F) MDI, Fluticasone propionate/salmeterol (F/SC) DPI |
| NCT00276458 To Evaluate Ezetimibe Plus Atorvastatin Versus Atorvastatin in Patients With High Cholesterol Not Controlled on Atorvastatin 20 mg (0653-079)(COMPLETED) | Hypercholesterolemia | P3 | Completed | 196 | RCT, Double-blind | Comparator: atorvastatin, Comparator: Placebo, Comparator: ezetimibe, Comparator: Placebo. |
| NCT00076973 An Investigational Drug Study to Treat Respiratory Symptoms Associated With Respiratory Syncytial Virus (RSV) Bronchiolitis (0476-272) | Bronchiolitis | P3 | Completed | 1,125 | RCT, Double-blind | montelukast sodium, Comparator: placebo |
| NCT00943397 Extended Safety Study of Montelukast in Infants and Young Children With Chronic Asthma (0476-232) | Asthma | P3 | Completed | 190 | RCT, Open-label | montelukast sodium, Comparator: Usual Care |
| NCT01723579 Efficacy and Safety of Oral NOMAC-E2 in Indian Women (P07057/MK-8175A-017) | Contraception | P3 | Withdrawn | — | Open-label | Nomegestrol acetate (NOMAC), Estradiol (E2) |
| NCT00145509 40 Week Trial to Study the Safety of Asenapine When Added to Lithium or Valproate in the Treatment of Bipolar Disorder (A7501009)(P05786) | Bipolar Disorder | P3 | Completed | 77 | Double-blind | Asenapine, Placebo |
| NCT00651391 Effect of Ezetimibe Plus Simvastatin on Flow-Mediated Brachial Artery Vasoactivity in Subjects With Primary Hypercholesterolemia (Study P03336) | Hypercholesterolemia, Atherosclerosis | P3 | Terminated | 28 | RCT, Double-blind | Ezetimibe + Simvastatin, Simvastatin, Placebo |
| NCT00156104 Efficacy and Safety of Asenapine With Placebo and Haloperidol (41023)(P05926)(COMPLETED) | Schizophrenia | P3 | Completed | 460 | RCT, Double-blind | Asenapine, Asenapine, Haloperidol |
| NCT00968149 A Study Comparing Montelukast With Placebo in Children With Seasonal Allergic Rhinitis (0476-219)(COMPLETED) | Seasonal Allergic Rhinitis | P3 | Completed | 413 | RCT, Double-blind | montelukast sodium, Comparator: Placebo |
| NCT00095004 Study to Test an Approved Product in the Early Treatment of Migraine (0462-066) | Migraine | P3 | Completed | 167 | RCT, Double-blind | MK0462, rizatriptan benzoate / Duration of Treatment: 1day, Comparator: placebo / Duration of Treatment: 1 day |
| NCT00110435 A Multicenter Study to Evaluate the Cholesterol Lowering Effects of Two Marketed Products in Patients With Type 2 Diabetes Mellitus and Hypercholesterolemia (MK-0653A-077) | Type 2 Diabetes Mellitus, Hypercholesterolemia | P3 | Completed | 1,229 | RCT, Double-blind | MK0653A, ezetimibe (+) simvastatin, Duration of Treatment: 4 wk placebo run in then 6 wk active, Comparator: atorvastatin |
| NCT00111722 Study to Test a Marketed Drug in the Treatment of Menstrual Migraine (0462-072) | Migraine | P3 | Completed | 393 | RCT, Double-blind | MK0462, rizatriptan benzoate / Duration of Treatment -1day, Comparator: placebo / Duration of Treatment - 1 day |
| NCT00511433 Effects on Ovarian Function of the Combined Oral Contraceptive NOMAC-E2 Compared to a COC Containing DRSP/EE (292003)(COMPLETED)(P05723) | Contraception | P3 | Completed | 48 | RCT, Open-label | NOMAC-E2, DRSP-EE |
| NCT00338260 Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study (0954-133) | Hypertension and Left Ventricular Hypertrophy (Thickening of the Main Pumping Chamber of the Heart) | P3 | Completed | 496 | RCT, Double-blind | MK0954, /Duration of Treatment : 5 Years, Comparator : atenolol /Duration of Treatment : 5 Years |
| NCT00731185 Mometasone Furoate Nasal Spray for Treatment of Nasal Polyposis After Surgery (Study P03218) | Nasal Polyps | P3 | Completed | 162 | RCT, Double-blind | Mometasone Furoate Nasal Spray, Placebo |
| NCT00651404 Ezetimibe Plus Atorvastatin Versus Atorvastatin Alone in Subjects With Primary Hypercholesterolemia (Study P03406) | Hypercholesterolemia, Atherosclerosis | P3 | Completed | 137 | RCT, Double-blind | Ezetimibe, Placebo |
| NCT01307033 A Long-term Study of the Safety of MK-0954A in Patients With Essential Hypertension (MK-0954A-351) | Hypertension | P3 | Completed | 278 | RCT, Double-blind | MK-0954A, MK-954H, Placebo to MK-0954A, Placebo to MK-954H |
| NCT00150176 To Determine Long Term Efficacy and Safety of Asenapine in Schizophrenic Patient Population (A7501012)(COMPLETED)(P05770) | Schizophrenia | P3 | Completed | 831 | RCT, Double-blind | Asenapine - Open Label, Placebo - Double Blind, Asenapine - Double Blind |
| NCT00092560 Two Investigational Drugs in Patients With Mixed Hyperlipidemia (0653-036) | Hypercholesterolemia, Hypertriglyceridemia | P3 | Completed | 587 | — | MK0653, ezetimibe, Comparator: fenofibrate monotherapy |
| NCT00156091 Long-Term Efficacy and Safety of Asenapine Using Olanzapine as a Positive Control (41512)(COMPLETED)(P05784) | Schizophrenia | P3 | Completed | 260 | RCT, Double-blind | Olanzapine, Asenapine |
| NCT00783224 A Comparative Study of Mometasone Furoate Nasal Spray and Fluticasone Propionate Nasal Spray in Patients With Perennial Allergic Rhinitis (Study P04512) | Perennial Allergic Rhinitis | P3 | Completed | 351 | RCT, Single-blind | Placebo for MF, Placebo for FP, Mometasone, Fluticasone |
| NCT01286207 Long-Term Exposure to Rizatriptan 5-mg and 10-mg Oral Tablet (Combined Extension Protocols MK-0462-022, MK-0462-025, MK-0462-029) | Migraine Disorders | P3 | Completed | 1,959 | RCT, Single-blind | Rizatriptan 5 mg, Rizatriptan 10 mg, Standard Care |
| NCT00423488 Ezetimibe and Simvastatin in Primary Hypercholesterolemia, Diabetes Mellitus Type 2, and Coronary Heart Disease (COMPLETED) | Hypercholesterolemia, Diabetes Mellitus, Type 2 | P3 | Completed | 93 | RCT, Double-blind | Ezetimibe 10 mg, Simvastatin 20 mg, Ezetimibe Placebo, Simvastatin 20 mg, Simvastatin Placebo |
| NCT00159796 3-week Study of Asenapine, Olanzapine and Placebo for Treatment of Bipolar Mania (P07009) | Bipolar Disorder | P3 | Completed | 489 | RCT, Double-blind | Asenapine, Olanzapine, Placebo |
| NCT01916980 Efficacy and Safety Study of Desloratadine (MK-4117) in Japanese Participants With Eczema/Dermatitis and Dermal Pruritus (MK-4117-202) | Eczema, Dermatitis | P3 | Completed | 94 | Open-label | Desloratadine 5 mg |
| NCT00090142 Montelukast in Exercise-Induced Bronchospasm - 2004 (0476-275) | Asthma, Exercise-Induced | P3 | Completed | 62 | RCT, Double-blind | Comparator: Montelukast, Comparator: Placebo |
| NCT00398931 FLEX - Long-term Extension of FIT (Fracture Intervention Trial)(0217-051) | Osteoporosis, Postmenopausal | P3 | Completed | 1,099 | RCT, Double-blind | MK0217, alendronate sodium / Duration of Treatment : 5 Years, Comparator : placebo (unspecified) /Duration of Treatment : 5 Years |
| NCT00963599 Montelukast in Seasonal Allergic Rhinitis - Fall 1999 Study (0476A-117) | Seasonal Allergic Rhinitis | P3 | Completed | 907 | RCT, Double-blind | Comparator: montelukast/loratadine, Comparator: montelukast, Comparator: loratadine, Comparator: placebo |
| NCT03768427 Ezetimibe (EZ)/Atorvastatin (Ator) (MK-0653C) vs. Ator in Chinese Hypercholesterolemic Participants (MK-0653C-439) | Hypercholesterolemia | P3 | Completed | 454 | RCT, Double-blind | Atorvastatin, Placebo for FDC EZ/Ator, Placebo for atorvastatin |
| NCT02741271 Study of Efficacy and Long-Term Safety of Mometasone Furoate in Combination With Formoterol Fumarate Versus Mometasone Furoate in Children (5 to 11 Years of Age) With Persistent Asthma (MK-0887A-087) | Asthma | P3 | Completed | 181 | RCT, Double-blind | MF MDI 100 mcg BID (Open Label), MF/F MDI 100/10 mcg BID, MF MDI 100 mcg BID, Albuterol/Salbutamol PRN, Prednisone/Prednisolone |
| NCT00789152 The Effect of Desloratadine and Levocetirizine on Nasal Obstruction (Study P03609) | Allergic Rhinitis | P3 | Completed | 81 | RCT, Double-blind | desloratadine, levocetirizine |
| NCT00101439 A Study to Evaluate the Effects of Ezetimibe (MK-0653) on the Postprandial (Following a Meal) Lipoprotein Response in Participants With Primary Hypercholesterolemia (High Cholesterol) (MK-0653-072)(COMPLETED) | Hypercholesterolemia | P3 | Completed | 58 | RCT, Double-blind | ezetimibe, Comparator: placebo |
| NCT00551447 A Study Comparing Ezetimibe Plus Simvastatin Versus Simvastatin Alone in Patients at Risk for Heart Disease (0653-023)(COMPLETED) | Coronary Disease | P3 | Completed | 616 | RCT, Double-blind | MK0653, ezetimibe / Duration of Treatment: 27 Weeks, MK0733, simvastatin / Duration of Treatment: 27 Weeks, Comparator: simvastatin / Duration of Treatment: 27 Weeks |
| NCT00276016 The Effects of Phenylephrine Compared With Those of Placebo and Pseudoephedrine on Nasal Congestion in Subjects With Seasonal Allergic Rhinitis (SAR)(P04579) | Rhinitis, Allergic, Seasonal | P3 | Completed | 39 | RCT, Single-blind | phenylephrine, pseudoephedrine, placebo |
| NCT00379288 Study of Mometasone Furoate/Formoterol Combination and Fluticasone/Salmeterol in Persistent Asthmatics Previously Treated With Inhaled Glucocorticosteroids (P04139) | Asthma | P3 | Completed | 404 | RCT, Open-label | mometasone furoate combination MDI 200/10 mcg BID, mometasone furoate combination MDI 400/10 mcg BID, Fluticasone/Salmeterol 250/50 mcg BID, Fluticasone/Salmeterol 500/50 mcg BID |
| NCT00447603 A Study of Losartan Compared to Losartan/HCTZ in Pediatric Patients With Hypertension (0954A-327) | Hypertension | P3 | Terminated | 40 | RCT, Double-blind | hydrochlorothiazide (+) losartan potassium, losartan potassium, Placebo for Losartan, Placebo for Losartan/HCTZ |
| NCT02668822 Efficacy and Safety of Etonogestrel + 17β-Estradiol Vaginal Ring (MK-8342B) in the Treatment of Women With Primary Dysmenorrhea (MK-8342B-060) | Dysmenorrhea | P3 | Terminated | 18 | RCT, Double-blind | ENG 125 μg + E2 300 μg vaginal ring (MK-8342B), Placebo vaginal ring, Ibuprofen |
| NCT00251576 Aggrastat to Zocor (AtoZ) - the Use of Two Approved Drugs to Treat Patients Who Have Experienced Chest Pain or a Heart Attack (0733-180) | Acute Coronary Syndrome | P3 | Completed | 4,497 | RCT, Double-blind | A-Phase: tirofiban; Z-Phase simvastatin, Duration of Treatment: A-Phase: minimum suggested 48 hours, maximum suggested 108 hours. Z-Phase: 2 years, Comparator: A-Phase: low molecular weight heparin, unfractionated heparin, Duration of Treatment: A-Phase: low molecular weight heparin, 2 to 8 days; unfractionated heparin, minium suggested 48 hours, maximum 108 hours, Duration of Treatment: Z-Phase, 2 years. |
| NCT00383240 Effects of Mometasone Furoate/Formoterol Combination Versus Mometasone Furoate Alone in Persistent Asthmatics (Study P04334AM1)(COMPLETED) | Asthma | P3 | Completed | 781 | RCT, Double-blind | mometasone furoate/formoterol fumarate combination MDI 200/10 mcg BID, Mometasone furoate MDI (MF MDI) 200 mcg, formoterol fumarate 10 mcg, Placebo |
| NCT00092131 Montelukast in Exercise-Induced Bronchospasm - 2003 (0476-270) | Asthma, Exercise-Induced | P3 | Completed | 51 | RCT, Double-blind | Comparator: Montelukast, Comparator: Placebo |
| NCT00156117 Efficacy and Safety of Asenapine With Placebo and Olanzapine (41021)(P05933) | Schizophrenia | P3 | Completed | 417 | RCT, Double-blind | asenapine, Placebo, olanzapine |
| NCT00289874 Montelukast in Pediatric Allergic Asthma (0476-336)(COMPLETED) | Asthma | P3 | Completed | 421 | RCT, Double-blind | montelukast sodium, Comparator: Placebo |
| NCT05264506 Contraceptive Efficacy and Safety of NOMAC-E2 Combined Oral Contraceptive | Contraception | P3 | Terminated | 3,055 | Open-label | NOMAC-E2 COC |
| NCT00413972 Effects of Vytorin Versus Placebo in Subjects With Primary Hypercholesterolemia (Study P04420) | Hypercholesterolemia | P3 | Completed | 392 | RCT, Double-blind | ezetimibe with simvastatin, Ezetimibe with Simvastatin, Ezetimibe with Simvastatin, Placebo |
| NCT00092053 Study of Investigational Drug in Osteoporosis (MK-0217-908) | Postmenopausal Osteoporosis | P3 | Completed | 203 | RCT, Double-blind | Placebo, ibandronate |
| NCT00092573 Study of Ezetimibe and Fenofibrate in Patients With Mixed Hyperlipidemia (0653-036)(COMPLETED) | Hypercholesterolemia, Hypertriglyceridemia | P3 | Completed | 576 | — | MK0653, ezetimibe, Comparator: fenofibrate monotherapy |
| NCT00269191 A Study to Assess the Safety and Efficacy of an Investigational Drug in Patients With Osteoarthritis (0663-071)(COMPLETED) | Osteoarthritis | P3 | Completed | 528 | RCT, Double-blind | MK0663, etoricoxib / Duration of Treatment 12 Weeks, Placebo or Ibuprofen / Duration of Treatment 12 Weeks |
| NCT00733005 Study of Nasonex in the Relief of Nasal Congestion in Patients With Seasonal Allergic Rhinitis (Study P05528)(COMPLETED) | Allergic Rhinitis | P3 | Completed | 324 | RCT, Double-blind | Mometasone furoate nasal spray (MFNS), Matching placebo nasal spray |
| NCT00535405 A Study to Assess the Cholesterol Lowering Effect of Ezetimibe/Simvastatin Combination Tablet Compared to Another Cholesterol Lowering Drug in Elderly Patients With High Cholesterol at High or Moderately High Risk for Coronary Heart Disease (0653A-128) | Hypercholesterolemia | P3 | Completed | 1,289 | RCT, Double-blind | Atorvastatin 10 mg, Ezetimibe 10 mg/simvastatin 20 mg, Atorvastatin 20 mg, Ezetimibe 10 mg/simvastatin 40 mg, Atorvastatin 40 mg |
| NCT00963469 Montelukast in Seasonal Allergic Rhinitis: Fall 2001 Study (0476-240) | Seasonal Allergic Rhinitis | P3 | Completed | 1,079 | RCT, Double-blind | montelukast sodium, Comparator: loratadine, Comparator: placebo |
| NCT00090298 Study to Evaluate the Cholesterol Lowering Effects of Two Marketed Drugs in Patients With Elevated Cholesterol Levels (0653A-058) | Hypercholesterolemia | P3 | Completed | 2,815 | RCT, Double-blind | MK0653A, ezetimibe (+) simvastatin, Comparator: Rosuvastatin |
| NCT00093899 A Study to Evaluate an Investigational Drug in Patients With Mixed Hyperlipidemia (0653A-071)(COMPLETED) | Hyperlipidemia, Hypercholesterolemia | P3 | Completed | 611 | RCT, Double-blind | ezetimibe (+) simvastatin |
| NCT00694369 A Study to Asses the Effect of MK0663 in the Treatment of Patients With Postoperative Dental Pain (0663-092) | Postoperative Dental Pain | P3 | Completed | 588 | RCT, Double-blind | Comparator: etoricoxib, Comparator: ibuprofen, Comparator: acetaminophen + codeine, Comparator: placebo |
| NCT01244815 Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder (P06107 Has an Extension [P05898; NCT01349907])(P06107) | Bipolar Disorder, Pediatric | P3 | Completed | 404 | RCT, Double-blind | asenapine, Placebo to match asenapine, Rescue medication |
| NCT00820027 Study of MK-0663/Etoricoxib in Postorthopedic Knee Replacement Surgery Pain (MK-0663-098) | Pain, Postoperative | P3 | Completed | 776 | RCT, Double-blind | Etoricoxib 90 mg, Etoricoxib 120 mg, Ibuprofen 600 mg, Matching Placebo for Etoricoxib 120 mg, Matching Placebo for Etoricoxib 90 mg, Matching Placebo for Ibuprofen, Morphine, Oxycodone |
| NCT03019575 Efficacy and Safety of Corifollitropin Alfa (MK-8962) in Combination With Human Chorionic Gonadotropin (hCG) in Adolescent Males With Hypogonadotropic Hypogonadism (HH) (MK-8962-043) | Hypogonadotropic Hypogonadism | P3 | Completed | 17 | Open-label | Corifollitropin alfa, hCG |
| NCT00546754 BP-EASE -Effectiveness of Losartan 50 mg/Hydrochlorothiazide (HCTZ) 12.5 mg Versus Valsartan 80 mg/HCTZ 12.5 mg Titrated as Needed in Patients With Essential Hypertension Not Controlled on Monotherapy (0954A-333) | Hypertension | P3 | Completed | 808 | RCT, Open-label | losartan potassium (+) hydrochlorothiazide, Comparator: Valsartan (+) Hydrochlorothiazide |
| NCT00540839 A Study of Montelukast (MK-0476) Compared With Fluticasone in Pediatric Participants With Chronic Asthma (MK-0476-303) | Asthma, Bronchial | P3 | Withdrawn | — | RCT, Double-blind | Montelukast sodium, Placebo to montelukast, Fluticasone propionate, Placebo to fluticasone |
| NCT00979901 Montelukast in Patients With Seasonal Allergic Rhinitis - Spring 2000 Study (MK-0476A-162)(COMPLETED) | Seasonal Allergic Rhinitis | P3 | Completed | 1,577 | RCT, Double-blind | Comparator: montelukast, Comparator: loratadine, Comparator: placebo, Comparator: montelukast/loratadine |
| NCT00541684 Health Assessment Study (0954-946) | Hypertension | P3 | Completed | 143 | RCT, Double-blind | MK0954, /Duration of Treatment : 16 Weeks, Comparator : atenolol /Duration of Treatment : 16 Weeks |
| NCT02275546 Performance and Safety of Vaginal Ring Applicator in Healthy Females (MK-8342A-063) | Contraception: Optional Applicator for Insertion of Vaginal Ring | P3 | Completed | 164 | RCT, Open-label | Placebo vaginal ring |
| NCT00265343 6-Month Extension Trial of Asenapine With Olanzapine in Negative Symptom Patients Who Completed the Protocol 25543 (25544)(P05777) | Schizophrenia | P3 | Completed | 306 | Double-blind | asenapine, olanzapine |
| NCT00092677 An Investigational Drug on Clinical Outcomes in Patients With Aortic Stenosis (Narrowing of the Major Blood Vessel of the Heart)(MK-0653A-043 AM4)(COMPLETED) | Aortic Stenosis | P3 | Completed | 1,873 | RCT, Double-blind | ezetimibe (+) simvastatin, Comparator: Placebo |
| NCT00732381 Study of Nasonex in the Relief of Nasal Congestion in Patients With Seasonal Allergic Rhinitis (Study P05529) | Allergic Rhinitis | P3 | Completed | 351 | RCT, Double-blind | Mometasone furoate nasal spray (MFNS), Matching placebo nasal spray |
| NCT01208181 A Two-Part, 12-Week Study of Etoricoxib as a Treatment for Rheumatoid Arthritis (RA) (MK-0663-107) | Arthritis, Rheumatoid | P3 | Completed | 1,404 | RCT, Double-blind | Etoricoxib 60 mg, Etoricoxib 90 mg, Placebo to Etoricoxib 60 mg, Placebo to Etoricoxib 90 mg |
| NCT01146418 Frozen-thawed Embryo Transfer (FTET) Cycle Follow-up Protocol (P06031) | Infertility | P3 | Completed | 307 | RCT, Double-blind | Corifollitropin alfa, recFSH (follitropin beta) |
| NCT00788710 A Study of MK0663/Etoricoxib for Post-Abdominal Hysterectomy Surgery Pain (0663-097)(COMPLETED) | Acute Pain Following a Total Abdominal Hysterectomy | P3 | Completed | 430 | RCT, Double-blind | etoricoxib (MK0663) 120 mg, Comparator: Placebo, etoricoxib (MK0663) 90 mg |
| NCT00307060 MK0954A-264 Filter Study (0954A-264)(COMPLETED) | Mild to Severe Hypertension | P3 | Completed | 274 | RCT, Double-blind | MK0954A, hydrochlorothiazide (+) losartan potassium / Duration of Treatment: 6 weeks, losartan / Duration of Treatment: 6 weeks |
| NCT00413062 Efficacy and Safety Study of the Combined Oral Contraceptive NOMAC-E2 Compared to a COC Containing DRSP/EE (292002)(P05722) | Contraception | P3 | Completed | 2,281 | RCT, Open-label | NOMAC-E2, DRSP-EE |
| NCT01098110 6-week Trial of the Efficacy and Safety of Asenapine Compared to Placebo in Participants With an Acute Exacerbation of Schizophrenia (P06124) | Schizophrenia | P3 | Completed | 532 | RCT, Double-blind | Asenapine 5 mg, Asenapine 10 mg, Placebo |
| NCT00898677 Rizatriptan 5 mg and 10 mg, Sumatriptan 100 mg, and Placebo Comparison Study (0462-030) | Migraine Headache | P3 | Completed | 1,268 | RCT, Double-blind | rizatriptan benzoate, rizatriptan benzoate, Comparator: sumatriptan, Comparator: Placebo |
| NCT01599494 An Efficacy and Safety Study of Corifollitropin Alfa (MK-8962) in Contrast to Recombinant FSH for Use in Controlled Ovarian Stimulation of Indian Women (P07056, Also Known as MK-8962-029) | Infertility | P3 | Withdrawn | — | RCT, Open-label | MK-8962, recFSH, Ganirelix, human Chorionic Gonadotropin (hCG), Progesterone |
| NCT01916967 An Efficacy and Safety Study of Desloratadine (MK-4117) in Japanese Participants With Chronic Urticaria (MK-4117-201) | Urticaria | P3 | Completed | 239 | RCT, Double-blind | Desloratadine, Placebo |
| NCT00117338 A Study of an Intravenous Drug in Pediatric Patients With Acute Asthma (0476-301) | Asthma | P3 | Completed | 276 | RCT, Double-blind | montelukast sodium, Comparator: placebo (unspecified) |
| NCT00389740 A Comparison Study With Alendronate and Raloxifene in Postmenopausal Women With Osteoporosis (0217-189) | Osteoporosis, Postmenopausal | P3 | Completed | 400 | RCT, Double-blind | MK0217, /Duration of Treatment : 12 Months, Comparator : raloxifene hydrochloride /Duration of Treatment : 12 Months |
| NCT01437111 Study of MK-217A/Alendronate Sodium 70-mg/Vitamin D3 5600 IU Combination Tablet (MK-0217A-329) | Osteoporosis | P3 | Completed | 200 | Open-label | MK-217A/Alendronate Sodium 70-mg/Vitamin D3 5600 IU Combination Tablet |
| NCT00383721 Effects of Mometasone Furoate/Formoterol Combination Versus Formoterol and Mometasone Furoate Alone in Chronic Obstructive Pulmonary Disease (COPD) (Study P04230AM4)(COMPLETED) | Chronic Obstructive Pulmonary Disease (COPD) | P3 | Completed | 1,196 | RCT, Double-blind | Mometasone furoate/formoterol (MF/F) combination, Mometasone furoate/formoterol (MF/F) combination, Mometasone furoate MDI (MF MDI), Formoterol MDI, Placebo |
| NCT00728416 Study of Nasonex in the Relief of Nasal Congestion in Patients With Seasonal Allergic Rhinitis (Study P05583) | Allergic Rhinitis | P3 | Completed | 333 | RCT, Double-blind | Mometasone furoate nasal spray (MFNS), Matching placebo nasal spray |
| NCT00782184 Ezetimibe/Simvastatin (10 mg/40 mg) vs. the Doubling of Atorvastatin in High Risk Participants (MK-0653A-134 AM1)(COMPLETED) | Hypercholesterolemia | P3 | Completed | 250 | RCT, Double-blind | ezetimibe/simvastatin 10/40, atorvastatin 40 mg, atorvastatin 20 mg |
| NCT00393211 Effect of Etoricoxib to Treat Chronic Low Back Pain (0663-042) | Recurrent Low Back Pain | P3 | Completed | 319 | RCT, Double-blind | MK0663, Etoricoxib / Duration of Treatment : 12 Weeks, Comparator : placebo (unspecified) /Duration of Treatment : 12 Weeks |
| NCT03861559 Onset of Action of Mometasone Furoate (MK-0887/SCH 032088) Nasal Spray Compared With Placebo in Seasonal Allergic Rhinitis (C93-184) | Rhinitis, Allergic, Seasonal | P3 | Completed | 201 | RCT, Double-blind | mometasone furoate nasal spray, placebo nasal spray |
| NCT00406783 Study for the Treatment of Intermittent Allergic Rhinitis With Desloratadine (Study P04683) | Rhinitis, Allergic, Seasonal, Rhinitis, Allergic, Perennial | P3 | Completed | 547 | RCT, Double-blind | 5-mg Desloratadine, Placebo |
| NCT00127166 Two Investigational Drugs in the Prevention of Airway Constriction Brought on by Exercise in Participants With Asthma (0476-911) | Exercise Induced Asthma | P3 | Completed | 154 | RCT, Double-blind | Montelukast sodium, Salmeterol xinafoate, Fluticasone propionate, Montelukast matching placebo, Salmeterol matching placebo |
| NCT00092612 Co-administration Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-802)(COMPLETED) | Hypercholesterolemia, Coronary Disease | P3 | Completed | 372 | RCT, Double-blind | MK0653, ezetimibe, Comparator: ezetimibe, placebo |
| NCT00212771 Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25520)(P05846) | Schizophrenia, Schizoaffective Disorder | P3 | Completed | 440 | RCT, Double-blind | asenapine, olanzapine |
| NCT00174265 6-Month Extension Trial of Asenapine With Olanzapine in Negative Symptoms Patients Who Completed the First 6- Month Trial (A7501014)(COMPLETED)(P05772) | Schizophrenia | P3 | Completed | 196 | Double-blind | asenapine, olanzapine |
| NCT00396175 Effects of Finasteride on Serum Prostate-Specific Antigen (0906-111) | Androgenetic Alopecia | P3 | Completed | 355 | RCT, Double-blind | MK0906, finasteride / Duration of Treatment : 48 Weeks, Comparator : placebo (unspecified) / Duration of Treatment : 48 Weeks |
| NCT00090168 Cholesterol Lowering Level of MK0653A+Simvastatin in Patients With Hypercholesterolemia and Atherosclerotic or Coronary Vascular Disease (0653A-806)(COMPLETED) | Hypercholesterolemia, Atherosclerotic Disease | P3 | Completed | 435 | RCT, Double-blind | MK0653A , ezetimibe (+) simvastatin, Comparator: atorvastatin, Duration of Treatment: 6 weeks |
| NCT00395603 Vytorin Treating Uncontrolled Lipids (VyTUL) Study (0653A-122) | Cardiovascular Diseases, Diabetes Mellitus | P3 | Terminated | 550 | RCT, Open-label | MK0653A, ezetimibe (+) simvastatin / Duration of Treatment: 6 Weeks, Comparator: atorvastatin / Duration of Treatment: 6 Weeks |
| NCT00132717 A 12 Week Study of MK0653A in Patients Who Have Been Hospitalized for a Possible Heart Problem (0653A-808) | Hypercholesterolemia | P3 | Completed | 450 | RCT, Open-label | MK0653A (ezetimibe [+] simvastatin), Comparator: atorvastatin, Comparator: fluvastatin, Comparator: lovastatin, Comparator: pravastatin, Comparator: rosuvastatin, Comparator: simvastatin |
| NCT01386125 A Study of the Effectiveness and Safety of Mometasone Furoate Nasal Spray (MFNS, SCH 032088) for the Treatment of Nasal Polyps (P05604) | Nasal Polyps | P3 | Completed | 748 | RCT, Double-blind | Mometasone Furoate Nasal Spray (MFNS), Placebo for MFNS |
| NCT00212836 Efficacy and Safety of Asenapine Compared With Olanzapine in Patients With Persistent Negative Symptoms of Schizophrenia (25543)(COMPLETED)(P05817) | Schizophrenia | P3 | Completed | 481 | RCT, Double-blind | asenapine, olanzapine |
| NCT00092599 Investigational Drug Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-801) | Hypercholesterolemia, Coronary Disease | P3 | Completed | 410 | RCT, Double-blind | MK0653, ezetimibe, Comparator: ezetimibe, placebo |
| NCT00542087 Etoricoxib vs. Diclofenac in OA (0663-805)(COMPLETED) | Osteoarthritis | P3 | Completed | 516 | RCT, Double-blind | MK0663, etoricoxib / Duration of Treatment: 6 Weeks, Comparator: diclofenac sodium / Duration of Treatment: 6 Weeks |
| NCT00654095 Coadministration of Ezetimibe and Atorvastatin in Patients With Primary Hypercholesterolemia (P05456) | Hypercholesterolemia | P3 | Completed | 146 | Open-label | Ezetimibe, atorvastatin |
| NCT00489346 A Study to Evaluate MK0476 and Fluticasone to Control Asthma in Patients With Mild Persistent Asthma (0476-910) | Asthma, Bronchial | P3 | Completed | 994 | RCT, Double-blind | MK0476, montelukast sodium / Duration of Treatment: 1 Year, Comparator : fluticasone propionate / Duration of Treatment: 1 Year |
| NCT05014568 Tapinarof for the Treatment of Atopic Dermatitis in Children and Adults | Atopic Dermatitis | P3 | Completed | 407 | RCT, Double-blind | tapinarof cream, 1%, Vehicle cream |
| NCT05032859 Tapinarof for the Treatment of Atopic Dermatitis in Children and Adults (DMVT-505-3102) | Atopic Dermatitis | P3 | Completed | 406 | RCT, Double-blind | tapinarof cream, 1%, vehicle cream |
| NCT00442117 A Comparison of Mometasone Furoate DPI Versus Budesonide DPI in Budesonide DPI in Asthmatics (Study P04880) | Asthma | P3 | Completed | 180 | RCT, Open-label | mometasone furoate dry powder inhaler, Budesonide DPI |
| NCT03879772 Dose-Ranging Study of Mometasone Furoate (MK-0887/SCH 032088) Nasal Spray in the Treatment of Children (Ages 6-11) With Seasonal Allergic Rhinitis (C95-161) | Rhinitis, Allergic, Seasonal | P3 | Completed | 679 | RCT, Double-blind | Mometasone furoate nasal spray, Beclomethasone dipropionate nasal spray, Placebo nasal spray, Chlorpheniramine maleate syrup |
| NCT00129402 Effects of Ezetimibe With Simvastatin in the Therapy of Adolescents With HeFH (Study P02579) | Hypercholesterolemia | P3 | Completed | 248 | RCT, Double-blind | ezetimibe with simvastatin, simvastatin |
| NCT00409773 Ezetimibe/Simvastatin in Patients With Metabolic Syndrome (0653A-107)(COMPLETED) | Hypercholesterolemia, Metabolic Syndrome | P3 | Completed | 1,143 | RCT, Double-blind | ezetimibe (+) simvastatin, Comparator: atorvastatin calcium, Comparator: Placebo (unspecified) |
| NCT00159783 40 Week Extension Study Of Asenapine and Olanzapine For Bipolar Disorder (A7501007)(COMPLETED)(P05857) | Bipolar Disorder | P3 | Completed | 218 | Double-blind | asenapine, Olanzapine |
| NCT00092729 An Investigational Drug Study in the Treatment of Primary Dysmenorrhea (0663-064) | Dysmenorrhea | P3 | Completed | 129 | RCT, Double-blind | etoricoxib (MK0663), Comparator: placebo (unspecified), Comparator: naproxen sodium |
| NCT02741245 A Study of the Efficacy and Safety of MK-0653H in Japanese Participants With Hypercholesterolemia (MK-0653H-832) | Hypercholesterolemia | P3 | Completed | 321 | RCT, Double-blind | Ezetimibe 10 mg, Rosuvastatin 2.5 mg, Placebo for Ezetimibe, Placebo for Rosuvastatin |
| NCT01852812 Study of the Safety and Pharmacokinetics of Montelukast (MK-0476) in the Treatment of Japanese Pediatric Participants With Perennial Allergic Rhinitis (MK-0476-520) | Perennial Allergic Rhinitis | P3 | Completed | 87 | Open-label | Montelukast Oral Granules (OG), Montelukast Chewable Tablets (CT) |
| NCT00480766 A Research Study to Evaluate the Safety and Effectiveness of MK0217 to Prevent and Treat Bone Loss (0217-193)(COMPLETED) | Osteoporosis | P3 | Completed | 173 | RCT, Double-blind | MK0217/Duration of Treatment : 12 Months |
| NCT00092820 Sitosterolemia Extension Study (0653-004)(COMPLETED) | Lipid Metabolism, Inborn Errors, Heart Disease | P3 | Completed | 58 | RCT, Double-blind | MK0653, ezetimibe, Comparator: placebo |
| NCT01709331 A Study of the Efficacy and Safety of Corifollitropin Alfa (MK-8962) in Combination With Human Chorionic Gonadotropin (hCG) in Adult Men With Hypogonadotropic Hypogonadism (HH) (P07937) | Hypogonadism, Hypogonadotropic Hypogonadism | P3 | Completed | 18 | Open-label | Corifollitropin alfa, hCG |
| NCT01154036 MK0653C in High Cardiovascular Risk Patients With High Cholesterol (Switch Study)(MK-0653C-162) | Hypercholesterolemia | P3 | Completed | 1,547 | RCT, Double-blind | ezetimibe 10 mg, atorvastatin, Comparator: rosuvastatin |
| NCT00092651 A Study of MK0653A (Ezetimibe (+) Simvastatin) in Patients With Hypercholesterolemia (0653A-038) | Hypercholesterolemia | P3 | Completed | 1,398 | RCT, Double-blind | MK0653A, ezetimibe (+) simvastatin, Comparators: simvastatin and ezetimibe |
| NCT00289887 Obese Hypertension Study (0954-315) | Hypertension | P3 | Completed | 261 | RCT, Double-blind | Comparator: losartan +/- HCTZ, Comparator: Placebo |
| NCT00449111 An Open Label Study to Assess the Efficacy, Safety and Tolerability of COZAAR Plus (Losartan Potassium 50mg/Hydrochlorothiazide 12.5mg) Possibly Titrated up to COZAAR Plus-F (Losartan Potassium 100mg/Hydrochlorothiazide 25mg) in Patients With Essential Hypertension (0954A-325) | Hypertension | P3 | Terminated | 11 | Open-label | MK0954, losartan potassium / Duration of Treatment - 12 weeks |
| NCT01307046 MK-0954A in Japanese Patients With Essential Hypertension Not Adequately Controlled With Losartan (MK-0954A-352) | Hypertension | P3 | Completed | 336 | RCT, Double-blind | MK-0954A, Losartan, Placebo to MK-0954A, Placebo to losartan 100 mg, Placebo to losartan 50 mg |
| NCT00739674 SAALT: Subtracting Salt and Adding Losartan Trial (0954A-335) | Hypertension | P3 | Completed | 992 | RCT, Open-label | losartan potassium (+ hydrochlorothiazide [HCTZ] + calcium channel blocker [CCB]) |
| NCT03885921 Safety and Tolerability Study of Ezetimibe (SCH 058235/MK-0653) Plus Atorvastatin or Simvastatin in Homozygous Familial Hypercholesterolemia (P01417/MK-0653-019) | Hypercholesterolemia | P3 | Completed | 44 | RCT, Double-blind | Ezetimibe, Atorvastatin, Simvastatin |
| NCT00127647 An Approved Drug to Study a New Indication for Allergic Rhinitis (0476-327) | Rhinitis, Allergic, Seasonal | P3 | Completed | 1,375 | RCT, Double-blind | montelukast sodium, Comparator: pranlukast |
| NCT00092716 Comparing an Investigational Medication Versus an Approved Medication in Reducing Cholesterol Levels (0653-025) | Hypercholesterolemia | P3 | Completed | 655 | RCT, Double-blind | MK0653, ezetimibe / Duration of Treatment: 28 weeks, Comparator: atorvastatin / Duration of Treatment: 28 weeks |
| NCT00308347 A Research Study to Evaluate the Renal (Kidney) Protective Effects of Losartan in Patients With Non-insulin Dependent Diabetes (0954-147)(COMPLETED) | Type 2 Diabetes, Nephropathy | P3 | Completed | 1,513 | RCT, Double-blind | MK0954, losartan / Duration of Treatment: mean 3.4 years, Placebo / Duration of Treatment: mean 3.4 years |
| NCT00398541 Evaluation of the Antihypertensive Effect of Hyzaar(R) and Cognitive Function of Hypertensive Patients (0954A-322) | Hypertension | P3 | Completed | 41 | RCT, Open-label | losartan potassium (+) hydrochlorothiazide |
| NCT00398151 To Evaluate the Inflammatory Markers in Adult Patients With Asthma Associated With Allergic Rhinitis Receiving Montelukast Therapy (0476-366) | Asthma | P3 | Completed | 58 | Open-label | MK0476, montelukast sodium / Duration of Treatment: 12 Weeks |
| NCT01277211 A Study to Evaluate the Effectiveness of NuvaRing® to Prevent Pregnancies in Chinese Women (P06450) | Contraception | P3 | Completed | 983 | RCT, Open-label | ENG 120 µg + EE 15 µg intravaginal ring, DRSP 3 mg + EE 30 µg |
| NCT01001234 A Study to Evaluate the Efficacy and Tolerability of Rizatriptan for Treatment of Acute Migraine in Children and Adolescents (MK-0462-082 AM7) | Migraine, Acute | P3 | Completed | 1,382 | RCT, Double-blind | rizatriptan, placebo, rizatriptan, placebo |
| NCT00092144 Study of an Approved Drug in Patients With Asthma (0476-289)(COMPLETED) | Asthma | P3 | Completed | 500 | RCT, Double-blind | MK0476, montelukast sodium / Duration of Treatment: 4 weeks, Comparator: placebo / Duration of Treatment: 4 weeks |
| NCT01462370 Study to Assess the Safety and Efficacy of Etoricoxib Versus Ibuprofen in the Treatment of Dysmenorrhea (MK-0663-145 AM1) | Dysmenorrhea | P3 | Completed | 139 | RCT, Double-blind | Etoricoxib, Ibuprofen, Placebo to etoricoxib, Placebo to ibuprofen, Acetaminophen 250 mg, isopropylantipyrine 150 mg and anhydrous caffeine 50 mg |
| NCT06134479 Comparison of Sequential CFA vs CFA +rFSH for Elective Fertility Preservation. | Fertility | P3 | Completed | 194 | RCT, Open-label | 150μg CFA (Elonva®) at stimulation day (SD) 1 and 100μg CFA(Elonva®) at SD 5, 150μg CFA (Elonva®) at SD 1 following by rFSH (Puregon®) 200IU daily from SD 8 until the day of the trigger |
| NCT00230984 IRAD2 : Patients With Respiratory Failure at Home | Chronic Respiratory Failure, Nutritional Depletion | P3 | Completed | 200 | RCT, Open-label | Oral dietary supplements (563 kcal/d), RESPIFOR, 160 mg/d of oral testosterone undecanoate in men, 80 mg/d in women |
| NCT00139815 Michelangelo - Oasis 5 | Thromboembolism | P3 | Completed | 20,078 | RCT, Double-blind | Fondaparinux, enoxaparin |
| NCT00446186 MK0476 Study in Adult Patients With Allergic Rhinitis (0476-378) | Rhinitis Allergic | P2 | Completed | 945 | RCT, Double-blind | MK0476, montelukast sodium / Duration of Treatment: 2 Weeks, Comparator: placebo / Duration of Treatment: 2 Weeks |
| NCT00779545 A Study of Mometasone Furoate Nasal Spray in Perennial Allergic Rhinitis (Study P03748)(COMPLETED) | Rhinitis, Allergic, Perennial | P2 | Completed | 455 | RCT, Double-blind | Placebo, Mometasone furoate, Mometasone furoate, Mometasone furoate, Mometasone furoate, Mometasone furoate |
| NCT00702806 Investigate Dose of Org 36286 to Initiate Multiple Follicular Growth in a Controlled Ovarian Hyperstimulation Protocol for IVF or IVF/ICSI (P07015) | Infertility, In Vitro Fertilization | P2 | Completed | 99 | RCT, Open-label | Org 36286, Puregon®, Orgalutran®, Pregnyl® |
| NCT01980940 The Single Dose Pharmacokinetics of Two and Proof of Efficacy of One New Etoricoxib Gel Formulation in Participants With Osteoarthritis (MK-0663-168) | Osteoarthritis Pain | P1P2 | Completed | 70 | RCT, Double-blind | Etoricoxib 75 mg 4% DMSO Gel, Etoricoxib 75 mg 4% PG Gel, Etoricoxib 150 mg 4% DMSO Gel, Etoricoxib 150 mg 4% PG Gel, Etoricoxib 163 mg 4% DMSO gel, Placebo, Etoricoxib 50 mg 4% DMSO, Matching Placebo to Etoricoxib 50 mg 4% DMSO Gel |
| NCT00967746 An Explorative Trial to Explore the Safety, Acceptability and Vaginal Bleeding Pattern of Three Etonogestrel-releasing Medicated Intrauterine Systems (Study P06060) | Contraception | P2 | Completed | 84 | RCT, Single-blind | Etonogestrel-releasing IUS, Etonogestrel-releasing IUS, Etonogestrel-releasing IUS |
| NCT00394160 Safety and Pk Study in 1- to 3- Month-Old Children With Bronchiolitis (0476-297) | Bronchiolitis | P2 | Completed | 12 | RCT, Double-blind | MK0476, Montelukast Sodium /Duration of Treatment : 14 Days |
| NCT00651807 A Trial to Investigate the Effectiveness and Safety of Org 3236 (Etonogestrel) Tablets in Men With Urinary Complaints Suggestive of a Benign Enlargement of the Prostate (304001)(P05806) | Benign Prostatic Hyperplasia (BPH) | P2 | Terminated | 16 | RCT, Double-blind | etonogestrel, Placebo |
| NCT01615874 Study of the Effect of Mometasone Furoate/Formoterol (MF/F), Montelukast and Beclomethasone Dipropionate (BDP) on Plasma Cortisol Levels of Children 5-11 Years Old With Persistent Asthma (P05574) | Asthma | P2 | Withdrawn | — | RCT, Single-blind | MF/F Metered Dose Inhaler (MDI) 25/5 mcg, MF/F MDI 50/5 mcg, MF/F MDI 100/5 mcg, BDP hydrofluoroalkane (HFA) 80 mcg, Montelukast tablets 5 mg (4 mg for children 5 years of age), Rescue medication: short-acting beta-2 agonist (SABA) MDI, Rescue medication: Prednisone/Prednisolone |
| NCT01709318 A Dose-Finding Study to Evaluate Ovarian Function and Vaginal Bleeding in Next Generation Rings (P06109/MK-8175A/MK-8342B-012) | Contraception | P2 | Completed | 666 | RCT, Double-blind | Nomegestrol acetate (NOMAC), Etonogestrel (ENG), Ethinyl estradiol (EE), Estradiol (E2) |
| NCT04042103 Maximal Use Study of Tapinarof Cream, 1% in Adults With Extensive Plaque Psoriasis | Plaque Psoriasis | P2 | Completed | 21 | Open-label | Tapinarof cream, 1% |
| NCT00988260 Japanese Bridging Trial of Org 37462 (Study P05969)(COMPLETED) | Controlled Ovarian Stimulation | P2 | Completed | 266 | RCT, Double-blind | Ganirelix, Ganirelix, Ganirelix |
| NCT00697255 A Phase 2 Trial to Evaluate if Corifollitropin Alfa (Org 36286), Followed by a Low Daily Dose of hCG or Recombinant FSH Can Induce Monofollicular Growth in Women With WHO Group II Anovulatory Infertility (P05693) | Ovulation Induction | P2 | Terminated | 8 | RCT, Open-label | corifollitropin alfa, recombinant Follicle Stimulating Hormone (recFSH), human Chorion Gonadotropin (hCG), hCG Bolus injection |
| NCT00816972 Desloratadine With Oxybutynin for the Treatment of Seasonal Allergic Rhinitis and Post-Nasal Drip (Study P04258)(COMPLETED) | Post-nasal Drip, Seasonal Allergic Rhinitis | P2 | Completed | 540 | RCT, Double-blind | Desloratadine 2.5 mg, Oxybutynin 2.5 mg, Placebo for Desloratadine 2.5 mg, Placebo for Oxybutynin 2.5 mg |
| NCT00264147 Rheumatoid Arthritis Dose Ranging Study (0663-086)(COMPLETED) | Rheumatoid Arthritis | P2 | Completed | 761 | RCT, Double-blind | etoricoxib, etoricoxib, etoricoxib, etoricoxib, Comparator: placebo, etoricoxib, Comparator: diclofenac |
| NCT01101464 A Trial to Determine Whether Two Differing Strength Tablets (3 x 5 mg Versus 1 x 15 mg) of Sublingually Org 5222 (Asenapine) Are Safe and Equal in Subjects With Schizophrenia or Schizoaffective Disorder (P05937) | Schizophrenia, Schizoaffective Disorder | P2 | Completed | 8 | RCT, Open-label | Asenapine 3x5mg followed by 1x15mg, Asenapine 1x15mg followed by 3x5mg |
| NCT02094235 A Phase 1/2 Study of E6005 in Pediatric Subjects With Atopic Dermatitis | Atopic Dermatitis | P1P2 | Completed | 62 | RCT, Double-blind | E6005 0.05%, Placebo, E6005 0.2% |
| NCT01179880 A Study of E6005 in Japanese Patients With Atopic Dermatitis | Atopic Dermatitis | P1P2 | Completed | 40 | RCT, Open-label | E6005, Placebo |
| NCT00666679 Study of Inhaled Corticosteroid Plus Montelukast Compared With Inhaled Corticosteroid Therapy Alone in Patients With Chronic Asthma (0476-386) | Asthma | P2 | Completed | 134 | RCT, Double-blind | Comparator: mometasone, Comparator: montelukast, Comparator: placebo (unspecified) |
| NCT01670656 A Study to Evaluate the Effect of Contraceptive Vaginal Rings on Primary Dysmenorrhea (P08257/MK-8175A/MK-8342B-057) | Dysmenorrhea | P2 | Completed | 439 | RCT, Double-blind | Nomegestrol acetate contraceptive vaginal ring (NOMAC-CVR), Etonogestrel containing contraceptive vaginal ring (ENG-CVR), Placebo, Ibuprofen |
| NCT00403793 Hormonal Contraception in Healthy Young Men (P42306)(COMPLETED)(P06057) | Contraception | P2 | Completed | 350 | RCT, Double-blind | etonogestrel with testosterone undecanoate, Placebo |
| NCT00878462 An Acceptability Study of Unflavored Asenapine Versus Raspberry Flavored Asenapine in Stable Patients With a Psychotic Disorder (P07010)(COMPLETED) | Psychosis | P2 | Completed | 174 | RCT, Open-label | Asenapine WHITE raspberry flavor (Treatment A), Asenapine RED raspberry flavor (Treatment B), Asenapine WHITE UNFLAVORED (Treatment C) |
| NCT05560646 A Study to Investigate Efficacy and Safety of OG-6219 BID in 3 Dose Levels Compared With Placebo in Participants Aged 18 to 49 With Moderate to Severe Endometriosis-related Pain | Endometriosis | P2 | Completed | 354 | RCT, Double-blind | OG-6219, Placebo |
| NCT05186805 Maximal Use Study of Tapinarof Cream, 1% in Pediatric Subjects With Extensive Atopic Dermatitis | Atopic Dermatitis | P2 | Completed | 36 | Open-label | Tapinarof cream, 1% |
| NCT00095017 Safety and Efficacy of an Investigational Drug Versus Placebo in the Treatment of Cancer Pain (0663-083) | Bone Neoplasms | P2 | Withdrawn | — | RCT, Double-blind | MK0663, etoricoxib / Duration of Treatment: 4 weeks |
| NCT00750750 Effectiveness and Safety of Once or Twice Daily Mometasone Nasal Spray Versus Amoxicillin Versus Placebo for Treatment of Acute Rhinosinusitis (Study P02683) | Acute Rhinosinusitis | P2 | Completed | 981 | RCT, Double-blind | mometasone furoate nasal spray (MFNS), MFNS, Amoxicillin, Placebo |
| NCT00702585 Study to Investigate the Optimal Dose of Org 36286 to Induce Monofollicular Ovulation in Women With WHO Group II Anovulatory Infertility (P07016) | Infertility | P2 | Completed | 55 | RCT, Double-blind | Org 36286, Placebo |
| NCT00242489 Etoricoxib in the Treatment of Osteoarthritis (MK-0663-007) | Osteoarthritis | P2 | Completed | 1,167 | RCT, Double-blind | MK0663, etoricoxib / Duration of Treatment: Part I (6 weeks), Part II (8 weeks), Placebo;Diclofenac 50mg(tid)/Duration of Treatment: Part I (Placebo) 6 weeks;Part II (Diclofenac) 8 weeks |
| NCT00598208 A Phase 2, Trial to Investigate the Dose-Response Relationship of a Single Injection of Org 36286 (Corifollitropin Alfa) to Initiate Multiple Follicular Growth in a Controlled Ovarian (Study 38826)(P06055)(COMPLETED) | Fertilization | P2 | Completed | 325 | RCT, Open-label | corifollitropin alfa, Follitropin beta injection |
| NCT00394069 PK Study in 3- to 6- Month-Old Children (0476-268)(COMPLETED) | Bronchiolitis | P2 | Completed | 14 | RCT, Double-blind | MK-0476, montelukast sodium |
| NCT00635882 Asthma Study Comparing Anti-Inflammatory Effects of 3 Doses of Mometasone Furoate/Formoterol Fumarate and Medium Dose Mometasone Furoate (Study P05122 AM1)(COMPLETED) | Asthma, Airway Inflammation | P2 | Completed | 93 | RCT, Double-blind | mometasone furoate/formoterol 100/10 mcg, mometasone furoate/formoterol 200/10 mcg, mometasone furoate/formoterol 400/10 mcg, MF DPI 200 mcg, MF MDI 200 mcg, Placebo |
| NCT01258803 A Study of the Bronchodilator Effect of Formoterol Fumarate Used in Combination With Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P06476 AM2) | Asthma | P2 | Completed | 92 | RCT, Single-blind | Formoterol Fumarate DPI, Mometasone Furoate/Formoterol Fumarate MDI (ex-actuator) without spacer, Mometasone Furoate/Formoterol Fumarate MDI (ex-actuator) with spacer, Placebo MDI with spacer, Placebo MDI without spacer, Mometasone Furoate DPI |
| NCT00552110 Study of Mometasone Furoate Nasal Spray and Oxymetazoline Nasal Spray Given Together Once A Day To Treat Seasonal Allergic Rhinitis (P04500) | Seasonal Allergic Rhinitis | P2 | Completed | 707 | RCT, Single-blind | OXY combination: mometasone furoate nasal spray (MFNS) and oxymetazoline nasal spray (OXY), OXY combination: mometasone furoate nasal spray (MFNS) and oxymetazoline nasal spray (OXY), mometasone furoate nasal spray (MFNS) once daily, oxymetazoline nasal spray (OXY) twice daily, Placebo |
| NCT00702351 A Trial of Single Dose Corifollitropin Alfa's Ability to Induce Multiple Follicular Growth During the First Week of Controlled Ovarian Stimulation for IVF or ICSI (38833)(P05788) | In Vitro Fertilization | P2 | Completed | 50 | Open-label | Org 36286 (corifollitropin alfa) |
| NCT01502371 A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223) | Asthma | P2 | Completed | 583 | RCT, Double-blind | Mometasone Furoate (MF) Metered Dose Inhaler (MDI), 25 mcg, Mometasone Furoate (MF) Metered Dose Inhaler (MDI), 50 mcg, Mometasone Furoate (MF) Metered Dose Inhaler (MDI), 100 mcg, Mometasone Furoate (MF) Dry Powder Inhaler (DPI), 100 mcg, Placebo Metered Dose Inhaler (MDI), Placebo Dry Powder Inhaler (DPI) |
| NCT01461941 A Phase 2 Study of E6005 in Patients With Atopic Dermatitis | Atopic Dermatitis | P2 | Completed | 78 | RCT, Single-blind | E6005, E6005 ointment (vehicle) |
| NCT00385437 Sedating Antidepressant Improves Driving Safety in Patients With Major Depressive Disorder | Depression, Excessive Daytime Sleepiness | P2 | Completed | 16 | RCT, Double-blind | Mirtazapine Treatment |
| NCT05504720 Evaluating Pembrolizumab, Trastuzumab and FLOT as Perioperative Treatment of HER2-positive, Localized Esophagogastric Adenocarcinoma | Esophagogastric Adenocarcinoma | P2 | Completed | 31 | Open-label | Pembrolizumab, Trastuzumab, FLOT |
| NCT00239590 Testosterone and Myocardial Perfusion in Coronary Heart Disease (CHD) | Coronary Heart Disease | P2 | Completed | 28 | RCT, Double-blind | Testosterone undecanoate |
| NCT00819377 Milrinone Inhaled in Cardiac Surgery | Valvular Stenosis, Valvular Insufficiency | P2 | Completed | 124 | RCT, Double-blind | Milrinone, Normal saline |
| NCT01345786 Bioequivalence of Nomegestrol Acetate (NOMAC) and Estradiol (E2) in Commercial Versus Phase 3 Pivotal Clinical Batches of NOMAC-E2 Tablets (P06328) | Healthy Postmenopausal Females | P1 | Completed | 158 | RCT, Open-label | Commercial NOMAC-E2, Phase 3 NOMAC-E2 "Batch A", Phase 3 NOMAC-E2 "Batch B" |
| NCT00739297 The Safety and Effectiveness of MK0476 (Montelukast) in Patients With Chronic Asthma (0476-388) | Chronic Asthma | P1 | Completed | 68 | RCT, Double-blind | Comparator: montelukast, Comparator: placebo |
| NCT00945035 Study of the Bioequivalence of the 20% and 30% Etoricoxib Tablet Formulations (0663-070) | Pain | P1 | Completed | 36 | RCT, Open-label | etoricoxib, Comparator: etoricoxib |
| NCT00953680 Bioequivalence of Losartan and Hydrochlorothiazide (HCTZ) Combination Tablet and Coadministration of Its Components (0954A-306) | Hypertension | P1 | Completed | 77 | RCT, Open-label | losartan potassium (+) hydrochlorothiazide (HCTZ), losartan potassium, hydrochlorothiazide (HCTZ) |
| NCT01236430 A Study to Determine the Bioequivalence of SCH 900068 Compared to Marketed Products (Protocol No. P07551) | Hyperlipidemia | P1 | Completed | 200 | RCT, Open-label | Ezetimibe, Ezetimibe/atorvastatin 10mg/10mg FDC, Atorvastatin 10mg, Atorvastatin 80mg, Ezetimibe/atorvastatin 10mg/80mg FDC |
| NCT00636207 A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Inhaled Montelukast (MK-0476) in Participants With Mild or Moderate Asthma (MK-0476-380 AM3)(COMPLETED) | Asthma | P1 | Completed | 46 | RCT, Double-blind | Montelukast, Placebo |
| NCT00711607 A Trial to Assess the Pharmacokinetic Profile (e.g., Uptake, Distribution and Excretion of a Substance in the Body) of Nomegestrol Acetate (NOMAC), Estradiol (E2) and Estrone (E1) After Multiple and Single Dose Administration of the Combined Oral Contraception NOMAC-E2 (COMPLETED)(P05822) | Healthy | P1 | Completed | 25 | RCT, Double-blind | nomegestrol acetate and estradiol |
| NCT00604812 Drug Study in Pediatric Subjects With Migraines (MK0462-083 AM1) | Migraine Disorders | P1 | Completed | 31 | RCT, Double-blind | rizatriptan benzoate (5 mg), rizatriptan benzoate (10 mg), Rizatriptan 5 mg Placebo, Rizatriptan 10 mg Placebo |
| NCT01206517 A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Sublingual Asenapine in a Pediatric Population With Schizophrenia or Bipolar I Disorder (P06522 AM1) | Schizophrenia, Bipolar I Disorder | P1 | Completed | 30 | Open-label | Asenapine 2.5 mg, Asenapine 5 mg, Asenapine 10 mg |
| NCT00664937 Exercise Induced Bronchoconstriction (0476-359) | Asthma, Exercise-induced | P1 | Completed | 24 | RCT, Double-blind | montelukast sodium, Comparator: placebo (unspecified) |
| NCT00651144 Assessment of Potential Interaction Between Ezetimibe and Rosuvastatin in Healthy Subjects With High Cholesterol (P03317) | Hypercholesterolemia, Atherosclerosis | P1 | Completed | 40 | RCT, Single-blind | Ezetimibe + Rosuvastatin, Rosuvastatin, Placebo, Ezetimibe |
| NCT05330130 Impact of FSH Dosage During Ovarian Stimulation for IVF/ICSI in Granulosa Cells | Ovarian Function Insufficiency, Fertility Issues | P1 | Completed | 6 | Open-label | Follitropin beta injection 150 IU, Follitropin beta injection 300 IU |
| NCT00779532 Thorough QT/QTc Study of Multiple Oral Doses of NOMAC-E2 (Org 10486 0 + Org 2317) in Healthy Women (Study 292011)(P05802) | Contraception | P1 | Completed | 189 | RCT, Double-blind | Moxifloxacin, NOMAC-E2 (Org 10486-0 + Org 2317), Moxifloxacin placebo, NOMAC-E2 placebo |
| NCT00647933 An Open-label, Single Center Trial to Assess the Pharmacokinetics, Pharmacodynamics and Safety of Org 36286 (P07004) | Infertility | P1 | Completed | 24 | Open-label | Org 36286, Lyndiol® |
| NCT00943852 The Effect of Losartan and Losartan Plus Isosorbide Mononitrate on Central Blood Pressure Measurements (0954-317) | Hypertension | P1 | Completed | 13 | RCT, Double-blind | losartan potassium, Comparator: isosorbide mononitrate (ISMN), Comparator: losartan + ISMN, Comparator: losartan + ISMN, Comparator: Placebo |
| NCT00806416 A Study of the Bioequivalence of 70 mg Alendronate and 70 mg Alendronate in Combination With 2800 IU Vitamin D | Osteoporosis | P1 | Completed | 244 | RCT, Open-label | alendronate sodium (+) cholecalciferol, Comparator: alendronate |
| NCT00803790 A Study of the Bioequivalence of 70-mg Alendronate and 70-mg Alendronate in Combination With 5600 IU Vitamin D (MK0217A-253) | Osteoporosis | P1 | Completed | 318 | RCT, Open-label | alendronate sodium+vitamin D combination, Comparator: alendronate |
| NCT00641771 4-Week Study to Assess the Effect of Alendronate and Vitamin D3 Once Weekly on Fractional Calcium Absorption in Postmenopausal Osteoporotic Women (0217A-230) | Osteoporosis | P1 | Completed | 56 | RCT, Double-blind | alendronate sodium (+) cholecalciferol, Comparator: Placebo (unspecified) |
| NCT00653913 Evaluation of Potential for Drug Interaction Between SCH 58235 (Ezetimibe) and Pitavastatin (Study P03962)(COMPLETED) | Hypercholesterolemia | P1 | Completed | 18 | RCT, Open-label | SCH 58235, pitavastatin |
| NCT00653276 MD Ezetimibe Cyclosporine Interaction (0653-057) | Cholesterol | P1 | Completed | 13 | RCT, Open-label | ezetimibe, Comparator: cyclosporine |
| NCT00700076 Pilot Study of ORG 25935 Modulation of Ketamine-induced Behavioral and Cognitive Effects in Healthy Male Subjects | Healthy | P1 | Completed | 15 | RCT, Double-blind | Ketamine and Org 25935, Placebo and Ketamine |
| NCT01062867 First Administration to Man Of Org 25435 a New Intravenous Anesthetic | Anaesthesia | P1 | Completed | 26 | Open-label | ORG25435 |
| NCT00920361 Designated Drug Use Investigation 1 of Follistim Injection (Study P06130)(COMPLETED) | Fertilization in Vitro | Completed | 1,664 | — | Follitropin beta | |
| NCT01041807 Cozaar XQ Re-examination Study (MK-0954-349) | Hypertension | Completed | 669 | — | amlodipine/losartan | |
| NCT01065779 FOSAMAX PLUS and FOSAMAX PLUS D Re-examination Study (0217A-267) | Osteoporosis | Completed | 880 | — | FOSAMAX PLUS, FOSAMAX PLUS D | |
| NCT01333436 A Study to Evaluate Fasting/Postprandial Serum Apolipoprotein B-48 (ApoB-48) Levels in Diabetic Participants With Normal to Moderately High Low Density Lipoprotein-C (LDL-C) Levels (MK-0653A-259 AM1) | Dyslipidemia, Hypercholesterolemia | N/A | Completed | 93 | Open-label | — |
| NCT00723723 Compliance With LDL-Lowering Therapy (Study P05467)(COMPLETED) | Coronary Heart Disease, Hypercholesterolemia | Completed | 555 | — | Statin | |
| NCT01381679 Effect of Ezetimibe Treatment on Low-density Lipoprotein Cholesterol (LDL-C) Levels in Participants With Coronary Heart Disease (CHD) Already Treated With a Statin (MK-0653A-205 AM1) | Hypercholesterolemia | Completed | 1,682 | — | Ezetimibe | |
| NCT01294696 Survey of Osteoarthritis Real World Therapies (MK-0663-140) | Osteoarthritis | Completed | 1,261 | — | Standard of care for treatment of osteoarthritis (OA) of knee(s) | |
| NCT00903721 Nasonex® Nasal Suspension 50 μg Long-term Designated Drug Use Investigation (Study P05876) | Allergic Rhinitis | Completed | 3,806 | — | mometasone furoate | |
| NCT00702624 Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established in Clinical Trial P05690 (Care Program) (P05710) | Pregnancy, Neonates | Completed | 113 | — | Corifollitropin alfa, recFSH (follitropin beta), gonadatropin releasing hormone (GnRH) antagonist ganirelix, human chorion gonadotropin (hCG), progesterone, placebo-recFSH (follitropin beta), placebo-corifollitropin alfa, open-label recFSH (follitropin beta) | |
| NCT00702273 Follow-up Study of Frozen-thawed Embryo Transfer (FTET) Cycles After Cryopreservation of Embryos in Clinical Trial P05787 (P05716) | In Vitro Fertilization | Completed | 344 | — | 150 µg Corifollitropin Alfa, 200 IU RecFSH/Follitropin beta (Days 1 to 7), Placebo for Corifollitropin Alfa, Placebo for RecFSH/Follitropin beta, 200 IU RecFSH/Follitropin beta (Days 8 to hCG), Ganirelix, hCG, Progesterone | |
| NCT00704769 Response of Desloratadine Syrup in the Relief of Symptoms Associated With Perennial Allergic Rhinitis in Pediatric Patients (Study P04299) | Rhinitis | Completed | 591 | — | Desloratadine (assigned by investigator as part of normal practice) | |
| NCT00943683 Montelukast in Pediatric Patients Aged 6 to 24 Months With Asthma--Safety Study (0476-176) | Asthma | N/A | Completed | 256 | RCT, Double-blind | montelukast sodium, Comparator: Placebo |
| NCT01685424 Etoricoxib Prescribing Patterns and Adverse Events of Interest in Primary Care in the United Kingdom (MK-0663-162 AM1) | Osteoarthritis, Rheumatoid Arthritis | Completed | 79,189 | — | Etoricoxib | |
| NCT01495741 Post-Authorization Safety Surveillance Study of Asenapine in Participants With Bipolar Disorder (P08307) | Bipolar Disorder, Schizophrenia | Completed | 42 | — | — | |
| NCT00726856 Retrospective Survey Evaluating the Effectiveness and Safety of Dual Inhibition Lipid-lowering in the Treatment of Dyslipidemia (Study P05171)(COMPLETED) | Dyslipidemia | Completed | 1,200 | — | Ezetimibe 10 mg plus statin or ezetimibe 10 mg plus fenofibrate | |
| NCT01390415 A Study to Evaluate Whether Losartan Protects the Kidney in Hypertensive Diabetic Participants With Microalbuminuria (MK0954-365 AM1) | Hypertension | Completed | 136 | — | — | |
| NCT01140048 Respiratory Syncytial Virus (RSV) Follow-Up Study (MK-0476-374) | Respiratory Syncytial Virus Bronchiolitis | Completed | 343 | — | — | |
| NCT00909389 Post-marketing Surveillance of the Safety, Tolerability and Efficacy of Vytorin (Ezetimibe + Simvastatin) Tablet Among Filipino Patients (Study P05647) | Hypercholesterolemia | Completed | 4,748 | — | Vytorin (R) (Ezetimibe + Simvastatin) | |
| NCT01436253 Study of Lipid Control in Hyperlipidemic Participants (MK-0653-179) | Dyslipidemia | Completed | 2,196 | — | Hypolipemics | |
| NCT00705081 Evaluation of the LDL-C Lowering Effects of Ezetimibe Achieved in Co-administration Therapy With Statins in an Indonesian Population (Study P04276)(COMPLETED) | Hypercholesterolemia | Completed | 453 | — | ezetimibe, statin | |
| NCT00730132 Observational Study of Approaches to Lipid-Lowering Therapy in Russian Patients With Coronary Heart Disease <<Treat to Goal>> (Study P05464) | Coronary Heart Disease, Hypercholesterolemia | Completed | 712 | — | Ezetimibe, Statin | |
| NCT00702195 Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established During Phase II Clinical Trials of Org 36286 (Study 38817)(P06054)(COMPLETED) | Pregnancy | Completed | 29 | — | Org 36286 (corifollitropin alfa), Placebo, recFSH | |
| NCT00802789 Montelukast in Chronic Asthma | Asthma | Completed | 2,000 | — | — | |
| NCT01408615 A Post Marketing Observational Study of the Safety and Efficacy of Elonva (Corifollitropin Alfa) in General Practice (P08165) | Infertility, Female | Completed | 472 | — | corifollitropin alfa | |
| NCT00761527 Observation of Side Effects and Effectiveness of Desloratadine (Aerius) Syrup in Filipino Children (Study P05634) | Rhinitis, Allergic, Seasonal, Rhinitis, Allergic, Perennial | Completed | 2,980 | — | Desloratadine Syrup | |
| NCT00704444 A 12-week Post-marketing, Observational Study to Confirm the Safety and Efficacy of Zetia Alone or in Combination With Other Lipid-lowering Drugs in Japanese Subjects With Hypercholesterolemia (Study P05244) | Hypercholesterolemia, Familial Hypercholesterolemia | Completed | 11,332 | — | Ezetimibe, Ezetimibe + other lipid-lowering medication(s) | |
| NCT01077830 An Observational Follow-Up Study of the Incidence of Cancer and Mortality in Patients From the SEAS (Simvastatin and Ezetimibe in Aortic Stenosis) Trial (MK-0653A-043-10) | Cancer | Completed | 1,392 | — | — | |
| NCT01498770 An Observational Drug Utilization Study of Asenapine in the United Kingdom (P08308) | Bipolar Disorder | Completed | 42 | — | Asenapine, Aripiprazole, Quetiapine, Risperidone, Olanzapine, Ziprasidone, Iloperidone, Paliperidone, Lurasidone, Clozapine, Amisulpride, Sertindole, Zotepine | |
| NCT01304511 Post-Marketing Surveillance of the Safety and Efficacy of Orgalutran (Ganirelix)® | Fertilization in Vitro | Completed | 711 | — | Orgalutran | |
| NCT00702546 Follow-up Protocol on the Outcome of Frozen-thawed Embryo Transfer Cycles From Clinical Trial P05690 (P05711) | In Vitro Fertilization | Completed | 102 | — | corifollitropin alfa, recFSH (follitropin alfa), gonadatropin releasing hormone (GnRH) antagonist ganirelix, human chorion gonadatropin (hCG), progesterone, placebo-recFSH (follitropin alfa), placebo-corifollitropin alfa, open-label recFSH | |
| NCT00724789 Monitor the Incidence of Congenital Malformations in Infants of Women Who Have Been Treated With Ganirelix (Orgalutran®)(Study 38644)(P05966)(COMPLETED) | Pregnancy, Neonates | Completed | 2,066 | — | ganirelix, GnRH agonist | |
| NCT00704535 Evaluation of the Safety, Tolerability and Efficacy of Ezetimibe on a Select Population of Filipinos With Hypercholesterolemia (Study P04748)(COMPLETED) | Primary Hypercholesterolemia, Homozygous Familial Hypercholesterolemia | Completed | 4,105 | — | Ezetimibe | |
| NCT01368185 Impact of MK-0954A on Uric Acid in the Management of Hypertension (MK-0954A-366) | Hypertension | Completed | 1,705 | — | — | |
| NCT01572675 A Study of the Patterns of Use of Etoricoxib in France (MK-0663-148) | Osteoarthritis | Completed | 547 | — | etorocoxib, celecoxib | |
| NCT00702338 Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established in Clinical Trial P05693 (P05713) | Pregnancy, Neonates | Completed | 1 | — | corifollitropin alfa, recombinant Follicle Stimulating Hormone (recFSH), human Chorion Gonadotropin (hCG), hCG Bolus injection | |
| NCT01181778 Evaluation of Participant Responses to Educational Counseling About Different Combined Hormonal Contraceptive Choices (P06557) | Contraception | Completed | 1,919 | — | — | |
| NCT01414192 A Study to Design a Model Cohort for Analysis of Dyslipidemia (MK-0653A-204) | Dyslipidemia, Hypercholesterolemia | Completed | 3,215 | — | — | |
| NCT00724477 Retrospective Evaluation of the Percentage of Subjects Who Have Reached Their LDL-C Objectives After Treatment With INEGY (Study P05103)(COMPLETED) | Primary Hypercholesterolemia | Completed | 1,663 | — | INEGY | |
| NCT01005056 Post-marketing, Observational Study to Confirm the Safety and Efficacy of MARVELON (Study P06083) | Contraception | Completed | 3,838 | — | Ethinylestradiol + Desogestrel | |
| NCT00702988 Pregnancy & Neonatal Follow-up of Ongoing Pregnancies Established During Clinical Trial 38826 (Study 38827)(P06056)(COMPLETED) | Pregnancy, Neonates | Completed | 44 | — | Org 36286, recFSH | |
| NCT01077843 Post-authorization Safety Study of Etoricoxib and Other Anti-inflammatory Therapies in European Patients With Ankylosing Spondylitis (MK-0663-163) | Ankylosing Spondylitis | Completed | 27,381 | — | Etoricoxib, Other Cox-2 inhibitors, Other Non-selective NSAIDs | |
| NCT00702520 Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established in Clinical Trial 38833 (P05783) | Pregnancy, Neonates | Completed | 15 | — | Corifollitropin alpha (MK-8962, Org 36286) 100 ug, Corifollitropin alpha (MK-8962, Org 36286) 150 ug, Triptorelin, Recombinant follicle stimulating hormone (recFSH), Human chorionic gonadotprophin (hCG). | |
| NCT01703520 Finasteride (MK-0906) and Male Breast Cancer - A Register-Based Nested Case-Control Study (MK-0906-162/2003.021). | Male Breast Cancer | Completed | 575,216 | — | — | |
| NCT01077817 Observational Study of Incidence Rates of Esophageal Cancer in Women Taking Medications for the Prevention or Treatment of Osteoporosis (MK-0217A-352) | Esophageal Cancer, Squamous Cell Carcinoma | Completed | 684,815 | — | Alendronate, Etidronate, Ibandronate, Risedronate, Raloxifene | |
| NCT01327638 Safety of Etoricoxib (MK-0663) in Patients With Spondyloarthropathy (SpA)/Ankylosing Spondylitis (AS) in Sweden (EP07013.013.11.082) | Spondylarthropathies; Spondylitis, Ankylosing | Completed | 21,108 | — | etoricoxib, Other COX-2 inhibitor, nsNSAIDs | |
| NCT00723736 Safety of Aerius Syrup in Pediatric Patients Aged 1-5 Years Old With Allergic Rhinitis or Chronic Idiopathic Urticaria (Study P04446AM1)(COMPLETED) | Rhinitis, Urticaria | Completed | 100 | — | Desloratadine | |
| NCT01070966 Vytorin Reexamination Study (0653A-174) | Primary Hypercholesterolemia and Homozygous Familial Hypercholesterolemia (HoFH) | Completed | 2,089 | — | — | |
| NCT00705211 A 52-week Post-marketing, Observational Study to Confirm the Safety and Efficacy of Zetia Alone or in Combination With Other Lipid-lowering Drugs in Japanese Subjects With Hypercholesterolemia (Study P05245) | Hypercholesterolemia, Familial Hypercholesterolemia | Completed | 1,794 | — | Ezetimibe, Ezetimibe + other lipid-lowering medication(s) | |
| NCT00920634 Protocol for Drug Use Investigation of Follistim Injection (Study P06132)(COMPLETED) | Anovulation | Completed | 384 | — | Follitropin beta | |
| NCT00702234 Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established in Clinical Trial P05714 (Care Program)(P05715) | Pregnancy, Neonates | Completed | 268 | — | Corifollitropin alfa, GnRH antagonist, (rec)hCG, FSH, Progesterone | |
| NCT00724698 Evaluation of Desloratadine When Used in Patients With Either Allergic Rhinitis or Chronic Idiopathic Urticaria | Rhinitis, Urticaria | Completed | 3,011 | — | Desloratadine | |
| NCT05632731 Comparison of Clinical Outcomes in Fresh Cycle With Single Blastocyst Stage and Double Cleavage-stage Embryos: a Single-center, Non-blind, Randomized Controlled Study | Infertility, Female | N/A | Unknown | 1,236 | RCT, Double-blind | — |
| NCT01070953 EZETROL® Re-examination Study (MK0653-175)(COMPLETED) | Hypercholesterolemia | Completed | 4,467 | — | — | |
| NCT00703014 Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established in Clinical Trial P05787 (P05712) | Pregnancy, Neonates | Completed | 541 | — | Corifollitropin Alfa 150 μg, 200 IU RecFSH/Follitropin beta (Days 1 to 7), Placebo for Corifollitropin Alfa, Placebo for RecFSH/Follitropin beta, 200 IU RecFSH/Follitropin beta (Days 8 to hCG), Ganirelix, hCG, Progesterone | |
| NCT00805662 Nasal Oxcytocin During IUI | Idiopathic Infertility | N/A | Completed | 86 | RCT, Double-blind | oxytocin, placebo |
| NCT00524771 Transatlantic Active Surveillance on Cardiovascular Safety of NuvaRing (TASC) | Contraception | Completed | 34,100 | — | — | |
| NCT00875095 Impact of Sperm DNA Integrity on Artificial Reproductive Treatment (ART) | Sperm DNA Impact on ART Outcomes | Terminated | 8 | — | — | |
| NCT00374972 Combined Hormonal Versus Progestin Only Contraception During Lactation | Lactation | Withdrawn | — | — | — | |
| NCT06775626 Body Composition and Sport Performance Among Young Female Soccer Players Using Subdermic Etonogestrel | Menstrual Symptoms | Early P1 | SUSPENDED | 40 | Open-label | Etonogestrel 68mg implant |
| NCT00710606 Comparison of Serum Contraceptive Hormone Levels Between Normal Weight and Obese Users of the NuvaRing® | Pharmacokinetics | N/A | Completed | 40 | Open-label | NuvaRing, NuvaRing |
| NCT01107548 Prevention of Stroke and Dementia in Primary Care | Stroke, Dementia | N/A | Terminated | 3,908 | Open-label | — |
| NCT01219387 Evaluation of Anti-mullerian Hormone Levels as Predictive of IVF Outcomes in Women Over 38 Years Old | AMH Levels, Inhibin B Levels | Completed | 300 | — | — | |
| NCT06378489 The Use of Etonogestrel Contraceptive Implant as Treatment for Endometrial Hyperplasia Without Atypia: A Cohort Study | Endometrial Hyperplasia Without Atypia | Unknown | 60 | — | Etonogestrel implant | |
| NCT00492882 Study of Mechanisms of Anovulation in Polycystic Ovary Syndrome | Anovulation | Completed | 30 | — | usual administration of exogenous recombinant FSH | |
| NCT05116371 Control of Bleeding on Nexplanon in Latinx Patients | Contraception | Unknown | 144 | — | 150 mcg levonorgestrel/30 mcg ethinyl estradiol | |
| NCT05000489 Perceptions of LARC Among AYA With Chronic Illness | Chronic Conditions, Multiple | Completed | 67 | — | — | |
| NCT00135148 Decrease of Libido of Post-Operative Male-Female Transsexuals and a Healthy Female Control Group | Transsexualism | Completed | 150 | — | — | |
| NCT00475553 Management of Breakthrough Bleeding During Extended Therapy Use With NuvaRing® | Breakthrough Bleeding, Breakthrough Spotting | N/A | Completed | 75 | RCT, Open-label | — |
| NCT00357526 Oral Contraceptive Pills Compared to Vaginal Rings | Pregnancy | N/A | Completed | 130 | RCT, Open-label | OCPs |
| NCT00748839 Heparin-Induced Thrombocytopenia: Development and Validation of a Predictive Clinical | Heparin-induced Thrombocytopenia | Completed | 2,700 | — | — |